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Chronic metabolic diseases have been linked to
molecular signatures of mitochondrial dysfunction.
Nonetheless, molecular remodeling of the tran-
scriptome, proteome, and/or metabolome does not
necessarily translate to functional consequences
that confer physiologic phenotypes. The work here
aims to bridge the gap between molecular and
functional phenomics by developing and validating
a multiplexed assay platform for comprehensive
assessment of mitochondrial energy transduction.
The diagnostic power of the platform stems from a
modified version of the creatine kinase energetic
clamp technique, performed in parallel with multi-
plexed analyses of dehydrogenase activities and
ATP synthesis rates. Together, these assays provide
diagnostic coverage of the mitochondrial network
at a level approaching that gained by molecular
‘‘-omics’’ technologies. Application of the platform
to a comparison of skeletal muscle versus heart
mitochondria reveals mechanistic insights into
tissue-specific distinctions in energy transfer effi-
ciency. This platform opens exciting opportunities
to unravel the connection between mitochondrial
bioenergetics and human disease.INTRODUCTION
Mitochondria are the principal site of energy conversion in
mammalian systems and primarily responsible for establishing
the free energy of ATP hydrolysis (DGATP) through the process
of oxidative phosphorylation (OXPHOS). Defects in oxidative
metabolism represent a common manifestation of aging and
age-relatedmetabolic disorders such as obesity, diabetes, heart
disease, and cancer (Gonzalez Herrera et al., 2015; Muoio and
Neufer, 2012; Sun et al., 2016). The strong association between
mitochondrial metabolism and pathophysiological phenotypes
has also emerged as a prominent theme among studies thatCell Repo
This is an open access article under the CC BY-Nhave deployed discovery technologies, such as genomics, pro-
teomics, and metabolomics, to identify molecular signatures
prognostic of disease risk (Davies et al., 2016; Koves et al.,
2008; Overmyer et al., 2015; Williams et al., 2016). Together,
these findings provide traction for theories implicating mitochon-
drial dysfunction as a cornerstone ofmetabolic disease and have
sparked intense interest in drug development strategies target-
ing mitochondrial health.
Implicit in this field of study is the idea that complex disease
traits arise from metabolic flux limitations or perturbations
imposed by the sum of all aberrant changes in the quantity and
quality of mitochondrial proteins. In most cases, pathological re-
modeling of these organelles involves multiple enzyme com-
plexes, at multiple steps, along multiple oxidative pathways
that act cooperatively to transduce the energy in carbon fuels
to a more biologically accessible form of currency (i.e., DGATP).
Importantly, molecular remodeling at the level of the transcrip-
tome, proteome, and/ormetabolome does not necessarily trans-
late to functional consequences that confer physiologic pheno-
types. Thus, progress toward deciphering the precise role of
the mitochondria in disease etiology requires tools and methods
that can capture changes in metabolic and respiratory flux in
intact mitochondria working to regenerate ATP in the context
of a physiologically relevant energy charge. To this end, we
have developed a multiplexed platform for interrogating respira-
tory fluxes under multiple substrate and energetic conditions.
The goal of the project was to bridge the gap between molecular
and functional phenomics by developing a suite of assays that
permit modeling of in vivo mitochondrial energy transduction in
a comprehensive manner. Application of these assays to a func-
tional comparison between mouse skeletal muscle versus the
heart revealed several profound distinctions in energy transduc-
tion efficiency between the mitochondrial pools resident in these
two tissues. Herein, we provide a blueprint for building this plat-
form and a workflow for executing and interpreting the assays.
RESULTS
Working Model of Mitochondrial Energy Transduction
Before discussing the design and implementation of the mito-
chondrial diagnostics platform, it is important to review several
fundamental bioenergetics principles that formed the frameworkrts 24, 3593–3606, September 25, 2018 ª 2018 The Authors. 3593
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Mitochondrial Energy Transfer
(A–D) Simplified model (A) and detailed depictions (B–D) of mitochondrial
energy transfer and the corresponding control nodes. (B) Upper left box shows
several common mechanisms of metabolite exchange in the inner mitochon-
drial membrane. ‘‘IN’’ and ‘‘OUT’’ refer to substrate uptake into, or export
from thematrix, respectively. The enzymes (color-filled boxes) activated under
each substrate condition are depicted within distinct segments. Black filled,
primary (1) NAD-linked dehydrogenase; gray filled, secondary (2) NAD-linked
dehydrogenases; blue filled, FAD-linked dehydrogenases; white filled, non-
dehydrogenase enzymes. (C) The difference in redox potentials between
NADH/NAD+ and H2O/O2 (780 mV  (280 mV) = 1,060 mV) provides energy
for pumping of protons from the matrix to the inner-membrane space during
the process of electron transport. (D) depicts the increase in ATP free energy
as the ATP:ADP ratio is displaced from equilibrium during the process of
mitochondrial energy transfer.
3594 Cell Reports 24, 3593–3606, September 25, 2018for this project. First, experiments tasked with providing insights
into mitochondrial metabolism must consider the basic mecha-
nisms by which biological energy transduction proceeds, as
well as caveats of studying bioenergetics using a cell-free,
in vitro system. These considerations are modeled in Figure 1A,
which depicts mitochondrial energy transduction as a series
of inter-connected energy cells (i.e., batteries) that power a
sequential set of energy transformation steps. Inherent to this
model is the critical concept that the energy potential (i.e.,
‘‘charge’’) of any one cell is constrained by the maximal charge
of the preceding battery. The charging and discharging of each
battery are regulated by three distinct flux control nodes that
act as power generators to collectively convert the chemical
energy in electron-rich carbon substrates (‘‘Fuel’’) to ATP free
energy (DGATP). In intact cells, substrate availability can exert
substantial control over respiratory kinetics and thermody-
namics. By contrast, flux control at this step is eliminated when
isolated mitochondria are provided with saturating substrate
concentrations. Thus, the first control node under evaluation in
our experimental system (node 1) is the power generator defined
as the ‘‘Matrix Dehydrogenases’’ (Figure 1B). This node encom-
passes substrate uptake across the mitochondrial inner mem-
brane via a collection of proteins that mediate electroneutral
or electrogenic ion transfer, as well as catabolism by multiple
dehydrogenase enzymes that remove hydrogens while transfer-
ring electrons from specific carbon substrates to nicotinamide
adenine dinucleotide (NAD+) and/or protein-bound flavin
adenine dinucleotide (FAD). The resulting production of NADH
and FADH2 provides reducing power that drives the electron
transport system (ETS). Simply stated, the ‘‘Matrix Dehydroge-
nases’’ transfer the charge available in the ‘‘Fuel’’ cell into ‘‘Elec-
tron Potential Energy,’’ thus establishing the energetic driving
force for the subsequent transfer step. The efficiency of energy
transfer at node 1 can be assessed experimentally via the fluo-
rescent measurement of the NADH/NAD+ and/or FADH2/FAD
+
redox couples (Koretsky and Balaban, 1987). Importantly, the
specific subset of dehydrogenases engaged by these assays
depends on the substrates provided. It should be noted that
the common practice of adding high concentrations of malate
(>2 mM) to respiring mitochondria is intended to (1) promote
efflux and depletion of matrix tricarboxylic acid (TCA) cycle
intermediates via malate exchange with citrate, isocitrate, and
alpha-ketoglutarate, which prevents enzyme product inhibition;
and (2) eliminate succinate dehydrogenase (SDH) flux via ma-
late-fumarate equilibration, which results in feedback inhibition
of the enzyme. Alternatively, dehydrogenase flux can be limited
exclusively to SDH by adding succinate as the substrate in
combination with inorganic phosphate, which promotes ma-
late-phosphate exchange, along with rotenone, an inhibitor of
complex I that causes hyper-reduction of the NADH/NAD+
couple and feedback inhibition of malate dehydrogenase
(MDH). Thus, these strategies are designed to isolate fluxes
through specific dehydrogenases and/or enzyme complexes.
Node 2 (‘‘Electron Transport System’’; Figure 1C) represents
the ETS generator, which transfers electron potential energy
in the form of NADH/NAD+ and FADH2/FAD
+ to the electro-
chemical proton gradient known as the protonmotive force
(Dp; ‘‘Proton Potential Energy’’ cell). This process consists of a
series of oxidoreductase reactions in which electrons flow down
an energy gradient as they transfer by default to redox cofactors
with sequentially more positive reduction potentials, each
residing within a multi-subunit protein complex embedded in
the inner mitochondrial membrane. Molecular oxygen serves
as the final electron acceptor, resulting in the formation of a
water molecule. The exothermic transfer of electrons to oxygen
drives the pumping of protons from the matrix to the inner mem-
brane space at three locations (CI, CIII, and CIV), in turn estab-
lishing Dp. The electrical component of this potential can be
assessed using a variety of fluorescent cationic compounds
(Scaduto and Grotyohann, 1999), or via tetraphenylphospho-
nium (TPP) in conjunction with a TPP-selective electrode (Pal-
meira and Rolo, 2012). In node 3 (‘‘ATP Synthesis’’; Figure 1D),
the energy available in Dp drives the generation and transport
of ATP, as the proton current traverses the inner mitochondrial
membrane via the ATP synthase complex (CV) and the adenine
nucleotide translocase (ANT). Under most circumstances, pro-
ton flux is tightly coupled to OXPHOS, which is a demand-driven
process regulated by the rate of cellular ATP turnover and the
subsequent availability of ADP. An acute increase in ATP hydro-
lysis leads to a transient fall in cellular energy charge, which in
turn promotes proton flux and ATP resynthesis. However, it is
important to consider that Dp can also be dissipated by proton
leak and/or consumed by processes such as metabolite or ion
transport (e.g., Ca2+ uptake) (Figure S1). Thus, a drop in Dp
due either to elevated demands for ATP regeneration or proton
leak will result in a partial loss of ATP free energy, triggering
increased electron transport and proton pumping in effort to
defend and recharge DGATP. The net flux of the proton current
is reflected by the rate at which oxygen is reduced at CIV,
measured as the rate of mitochondrial oxygen consumption
(JO2), which therefore serves as the experimental measurement
of node 3.
In sum, mitochondria serve two primary functions: (1) ATP
resynthesis, and (2) displacement of the ATP/ADP ratio far
from equilibrium, by about 10 orders of magnitude. This means
that mitochondria are typically pumping ATP into a sea of ATP,
‘‘up an energetic hill.’’ The extent to which the ATP generator
at node 3 can displace the extra-mitochondrial ATP/ADP ratio
away from equilibrium dictates the free energy of ATP hydrolysis
(DGATP), which in turn determines the power available for cellular
work. The energy available to displace ATP/ADP depends
entirely on the potential energy harnessed in the steady-state
Dp, which in turn draws its charge from the steady-state redox
potential that is maintained by the dehydrogenase enzymes
and regulated by enzyme activities and fuel availability. As
such, a decline in capacity and/or efficiency within any of the po-
wer-generating control nodes will by default impact the energy
charge and discharge of all batteries, ultimately leading to a
loss in ATP free energy and ensuing biological consequences.
Thus, given the interconnectivity of the foregoing energy trans-
duction circuit, attempts to identify potential lesions in oxidative
metabolism would greatly benefit from comprehensive informa-
tion that enables one to diagnose shifts in flux control at each of
the three nodes duringmitochondrial respiration occurring under
near-physiologic energetic conditions. In other words, the
conventional approach of measuring JO2 alone in the contextof unlimited ADP availability (i.e., ATP/ADP ratio approaching
equilibrium) severely limits the diagnostic utility of that assay.
The Creatine Kinase Clamp Technique and the
Assessment of OXPHOS Conductance
Conventional respirometry assays measure JO2 in response to
an ADP bolus or an ADP clamp. In these assays, the ATP/ADP
ratio is essentially at or near equilibrium, which means the mito-
chondria are operating under conditions that are physiologically
irrelevant. The approach described here was designed to inter-
rogate amultitude ofmitochondrial fluxes undermore physiolog-
ically meaningful conditions using a population of mitochondria
isolated from a single mouse. The diagnostic power of the plat-
form stems from the application of a modified version of the cre-
atine kinase (CK) energetic clamp (Glancy et al., 2008, 2013;
Messer et al., 2004; Willis et al., 2016). This technique leverages
the enzymatic activity of CK, which couples the interconversion
of ATP and ADP to that of phosphocreatine (PCr) and free crea-
tine, to titrate the extra-mitochondrial ATP/ADP ratio. Impor-
tantly, the CK clamp permits assessment of respiratory control
across a range of ATP free-energy states (expressed herein in ki-
localories per mole and estimated per details in STAR Methods),
effectively modeling in vivo flux demands for ATP regeneration.
An increase in ATP energy charge (ATP/ADP ratio) mimics a
decrease in demand and vice versa. A simple analogy is that
the transition from high to low ATP/ADP ratio mimics the transi-
tion between rest and exercise; thus, the assay serves as an
in vitro stress test. Figure 2A depicts the concentrations of the
primary clamp components (ADP, ATP, Cr, PCr) across a span
of ATP free energies, which are varied via the sequential addition
of PCr from a starting concentration of 1mM to a final concentra-
tion of 30 mM. Consistent with the study by Glancy et al. (2013),
exposure of energized mitochondria to increasing ATP free
energies (i.e., more negative DGATP values corresponding to an
increased ATP/ADP ratio) progressively diminished respiratory
flux (Figure 2B). This is because a fall in demand facilitates re-
charging of the Dp battery, and consequently, proton pumping
at CIV is met with increasing backpressure. Plotting mito-
chondrial JO2 as a function of DGATP permits a calculation of
conductance (the reciprocal of resistance) throughout the entire
OXPHOS pathway, according to the equation I = V/R (Figure 2C),
wherein current (I) corresponds to the proton current (experi-
mentally represented via JO2) and voltage (V) is represented by
DGATP (Willis et al., 2016). The slope of the inverse relationship
between JO2 andDGATP reflects relative flux resistance (R) within
the entire mitochondrial OXPHOS energy transduction pathway,
such that the steeper slope observed in skeletal muscle mito-
chondria energized by glutamate/malate (G/M) as compared
to octanoylcarnitine/malate (Oct/M) (Figure 2D) indicates lower
resistance and greater conductance (sensitivity) in the context
of the respective substrate conditions (Glancy et al., 2013).
These results are interpreted as indication of a respiratory flux
limitation, and thus decreased responsiveness to energy chal-
lenge, when Oct/M is provided as substrate. In others words,
muscle mitochondria are better capable of responding to an en-
ergy deficit when provided with glutamate as opposed to fatty
acid substrate. It should be noted that the relationship between




















































































































A Figure 2. Assessment of Mitochondrial
Respiratory Conductance via the CK Clamp
(A) Changes in ADP, ATP, creatine (Cr), and
phosphocreatine (PCr) and the estimated free
energy of ATP hydrolysis (DGATP) during a typical
CK clamp experiment. The transition from a high to
low energy charge, and thus low to high energy
demand, mimics the transition from rest to
exercise.
(B–D) Representative JO2 trace (B) and linear
relationship between JO2 and DGATP during a
PCr titration experiment in skeletal muscle mito-
chondria energized with G/M (C) or G/M versus
Oct/M (D).
(E) Representative PCr titration experiments in
skeletal muscle mitochondria demonstrating the
linear range of the relationship between JO2 and
DGATP.(Figure 2E), further underscoring the caveats of interpretations
based on state 3 respiration kinetics.
Multiplexed Assessment of Mitochondrial DJ and
NAD(P)H/NAD(P)+ Redox State across Increasing ATP
Free Energies
A central bioenergetics tenet relevant to the goals of this proj-
ect is that shifts in JO2 and respiratory responsiveness are
difficult to interpret without corresponding information on the
energy charge of the redox and Dp batteries. Accordingly,
the platform we developed incorporates concurrent assess-
ments of mitochondrial membrane potential (DJ) and the
NAD(P)H/NAD(P)+ redox state. Mitochondrial DJ was as-3596 Cell Reports 24, 3593–3606, September 25, 2018sessed using the fluorescent cationic
dye tetramethylrhodamine methyl ester
(TMRM), which was selected because
this fluorophore is amenable to a multi-
plexed assay platform. Here, TMRM
emission spectra at 590 nm following
excitation at both 551 and 552 nm
were used to estimate DJ by converting
the 572/551 ratio to millivolts, based on
a KCl calibration curve performed in
the presence of valinomycin (Krumsch-
nabel et al., 2014). Next, the NAD(P)H/
NAD(P)+ redox state, expressed as a
percentage of complete reduction, was
obtained by a second fluorometric
reading based on NAD(P)H auto-fluores-
cence, in which emission intensity
at 450 nm is recorded following excitation
at 340 nm. These fluorometric assays
were performed with a QuantaMaster
Spectrofluorometer (QM-400; Horiba
Scientific) equipped with a tempera-
ture-controlled four-position multi-sam-
ple turret, which permits processing of
four samples per experiment. Simulta-
neous fluorescent measurements (Ex/Em; 340/450, 551/590, 572/590) alongside parallel respirometry
experiments using multiple O2K instruments permitted multi-
plexed assessment of respiratory conductance and associated
steady-state energetic potentials (i.e., DJ and NAD(P)H/
NAD(P)+) under various substrate combinations. Further details
pertaining to optimization and validation of these assays are
provided in STAR Methods and Figure S2.
Validating the Diagnostic Utility of the CK Clamp
Technique Using Respiratory Inhibitors
In theory, parallel measurements of JO2, DJ, and the NAD(P)H/
NAD(P)+ redox state should permit both the detection and gener-







Figure 3. Respiratory Conductance Work-
flow Localizes Distinct Sites of Resistance
Imposed by Specific Inhibitors
(A–H) Relationship between mitochondrial oxygen
consumption (JO2) and ATP free energy (DGATP) in
heart mitochondria energized with either Pyr/Mal
(A–D) or Oct/M (E–H) performed in the presence of
DMSO and (A–D) UK5099 or (E–H) oligomycin and
rotenone. In (E), the JO2 rates depicted to the right
of the dashed line, at DGATP = 0, represent
maximal, uncoupled JO2 induced via addition of
1 mM FCCP. (B and F) Slope of the relationships
between JO2 and DGATP depicted in (A) and (B),
respectively. (C and G) Mitochondrial DJ and
(D and H) NAD(P)H/NAD(P)+ redox state measured
under identical conditions to those displayed in
(A) and (E). Data are mean ± SEM. Differences
between DMSO and each inhibitor (UK5099, Rot,
Oligo) were analyzed by paired t tests. *p < 0.05,
**p < 0.001, and ***p < 0.0001. (E, G, and H) The
asterisks (*) above the data points correspond to
the DMSO versus Oligo comparison, while those
below correspond to DMSO versus Rot. n = 3–4/
group, where n represents 3–4 biological repli-
cates (i.e., mitochondrial preparations).To directly test this concept, experiments were conducted in iso-
lated heart mitochondria in the presence and absence of three
distinct respiratory inhibitors that act specifically at each of the
three nodes (Figures 1B–1D). Each inhibitor was applied at a
sub-saturating dose in the presence of increasing ATP free en-
ergies to simulate submaximal respiratory resistance (flux limita-
tion). The pyruvate carrier inhibitor, UK5099, was used to induce
resistance at control node 1 (‘‘Dehydrogenases’’) by restricting
substrate supply to the pyruvate dehydrogenase (PDH) complex
(Bricker et al., 2012). Application of resistance at this node
should limit the steady-state reduction potential generated by
PDH (i.e., NAD(P)H/NAD(P)+ redox state), therefore impairing
all subsequent energy transfer steps. The substrate combination
of pyruvate andmalate was utilized for these experiments to acti-
vate the PDH complex. Consistent with the predicted outcome,
addition of UK5099 imposed respiratory resistance compared to
DMSO-treated mitochondria (Figures 3A and 3B), while also
causing a relative depolarization of the DJ (Figure 3C) and aCell Reportsdecrease in NAD(P)H/NAD(P)+ (Figure 3D)
reduction potential. Thus, the observed
respiratory phenotype fit perfectly with
that expected by a flux limitation at
node 1.
We next used rotenone and oligomycin
to simulate resistance within nodes 2
(‘‘Electron Transport System’’) and 3
(‘‘ATPSynthesis’’), respectively. Rotenone
inhibits electron entry into the ETS at the
level of CI. Submaximal flux resistance at
this stage should impair energy transfer ef-
ficiency at all points downstream of CI,
while also imposing a bottleneck that re-
sults in the buildup of free energy in theform of redox potential. Thus, in experimental terms, rotenone
would be expected to decreaseboth JO2 and respiratory conduc-
tance due to relative depolarization ofDJ, while causing a hyper-
reduction in the NAD(P)H/NAD(P)+ redox state. This scenario was
indeed evident in isolated heart mitochondria energized with
Oct/M and treated with 9 nM rotenone (Figures 3E–3H; DMSO
versusRot). In contrast to rotenone, oligomycin inhibits CV, where
it restricts the transfer of energetic potential between the Dp and
DGATP. As such, this agent would also be predicted to lower
both JO2 and respiratory conductance, but with the bottleneck
nowoccurring furtherdownstream,abuildupof freeenergyshould
be observed at all preceding sites of the energy transduction
pathway. Consistent with this notion, exposure of isolated heart
mitochondria to 15 nM oligomycin led to a30% drop in respira-
tory conductance, combined with a relative hyper-polarization of
the DJ and hyper-reduction of the NAD(P)H/NAD(P)+ redox state
(Figures 3E–3H; DMSO versus Oligo). Addition of the uncoupling
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Figure 4. Respiratory Control in Mitochondria Isolated from Heart Compared to Skeletal Muscle
(A–C) Changes inmitochondrial (A) JO2, (B)DJ, and (C) NAD(P)H/NAD(P)
+ redox state as a function of ATP free energy (DGATP) and substrate: G/M, Pyr/M, Oct/M,
and Succ/Rot.
(D) The linear range of JO2, located to the left of the dashed line in (A), was used to calculate the corresponding slopes.
(E–G) Relationship between mitochondrial JO2 and DJ in the presence of (E) Pyr/M, (F) Oct/M, and (G) Succ/Rot. Data are mean ± SEM. Tissue-specific
differences in mitochondrial phenotypes were analyzed by Student’s t test. *p < 0.05, **p < 0.001, and ***p < 0.0001. n = 4–7 individual mice/group.(FCCP) (1mM), at the endof the respirometry experiments rescued
absolute rates of JO2 in oligomycin, but not the rotenone-treated
mitochondria (Figure 3E; rates to the right of the dotted line).
This is because uncoupling eliminates flux control imposed by
the ATP synthesis node (CV and/or ANT) and amplifies flux resis-
tance at the ETS node. In sum, rotenone and oligomycin led to
indistinguishable phenotypes at the level of respiratory conduc-
tance and NAD(P)H/NAD(P)+ reduction potential; however, the ef-
fects of the drugs diverged at the level of the DJ, in a manner
consistent with the known molecular target of each agent. Taken
together, these data validate the diagnostic power of the assay
platform and highlight its ability to identify and localize respiratory
resistance to one of three energy transfer control nodeswithin the
entire OXPHOS pathway.
Application of the Respiratory Diagnostics Platform
Reveals Tissue-Specific Conductance Phenotypes and
Dehydrogenase Limitations in Skeletal Muscle and
Heart Mitochondria
The assay platform was subsequently deployed to investigate
energy transfer inmitochondrial populations derived frommouse3598 Cell Reports 24, 3593–3606, September 25, 2018skeletal muscle as compared to heart. Notably, mitochondrial
content, as determined by the expression of CIII, CIV, and CV
(Larsen et al., 2012), were not different between skeletal muscle
and heart mitochondrial preparations when normalized to total
protein (Figures S4A and S4B). The substrate combinations em-
ployed for these assays included G/M, pyruvate/malate (Py/M),
Oct/M, and succinate/rotenone (Succ/R), each of which engage
a distinct set of dehydrogenase enzymes (Figure 1B). In the
presence of G/M and Pyr/M, both of which are NAD-linked sub-
strate combinations, absolute rates of JO2 as well as calculated
conductance measurements (Figures 4A and 4D; G/M and
Pyr/M) were as much as 4-fold greater in mitochondria from
skeletal muscle as compared to heart, a distinction that was
particularly pronounced in the context of G/M. By contrast,
upon exposure to Oct/M, both JO2 and respiratory conductance
(Figures 4A and 4D; Oct/M) were substantially lower inmitochon-
dria derived from skeletal muscle versus heart. Interestingly, the
presence of Succ/Rot produced similar maximal JO2 in skeletal
muscle and heart mitochondria (Figure 4A; Succ/Rot), but respi-
ratory conductance was greater in the latter group (Figure 4D;
Succ/Rot).
To localize the site of the substrate-specific flux limitations de-
tected by the foregoing conductance assays, measurements of
DJ (Figure 4B) and NAD(P)H/NAD(P)+ redox status (Figure 4C)
were performed simultaneously using the same two populations
of mitochondria. For each of the substrate conditions tested, the
mitochondrial pool that produced a more robust conductance
plot also produced a more polarized DJ and a more reduced
NAD(P)H/NAD(P)+ redox state. These results align with the respi-
ratory phenotype observed in the presence versus absence of
the pyruvate carrier inhibitor, UK5099 (Figure 3), and thus points
to substrate delivery and/or dehydrogenase activity (node 1) as
the primary node that explains the phenotypic distinctions
between muscle and heart mitochondria. For example, the low
respiratory conductance observed in heart mitochondria sup-
plied with G/M appeared to stem from insufficient substrate
flux through the enzymes that use those substrates to generate
electron potential energy (Figure 1B), thereby resulting in a lower
NAD(P)H/NAD(P)+ redox state. Likewise, the same was true
of skeletal muscle mitochondria when Oct/M served as the
substrate.
Adaptations in Energy Transfer Efficiency within Heart
Mitochondria Maximize DGATP across Physiological Flux
Demands
The lower respiratory conductance observed in heart as
compared to muscle mitochondria fueled by Pyr/M (Figures 4B
and 4D; Pyr/M) was accompanied by a relative hyper-polariza-
tion of DJ (Figure 4B; Pyr/M) and a slight hypo-reduction of
NAD(P)H/NAD(P)+ redox state (Figure 4C; Pyr/M). Lower respira-
tory conductance combined with heightened energetic potential
within theDp could indicate increased resistance in the ATP syn-
thesis control node, as demonstrated by the experiments with
low-dose oligomycin (Figure 3). However, unlike that observed
with oligomycin, hyper-polarization of DJ in heart mitochondria
energizedwith Pyr/Mwas accompanied by a relative decrease in
electron potential energy (i.e., lower NAD(P)H/NAD(P)+ redox), a
combination that instead implies enhanced energy transfer effi-
ciency (i.e., thermodynamics). Likewise, plotting JO2 against
DJ for high flux substrate combinations revealed a pronounced
rightward shift in the curves corresponding to heart mitochondria
(Figures 4E–4G), such that any given JO2 corresponded with a
more negative DJ, consistent with increased OXPHOS effi-
ciency. The hyper-polarized phenotype of heart mitochondria
was also apparent in Percoll-purified preparations (Figures S4F
and S4G). This relationship is of particular importance because,
in vivo, the energy available in the Dp determines the magnitude
to which the mitochondria can displace the ATP/ADP ratio from
equilibrium, which in turn drivesDGATP. Accordingly, our findings
suggest that heart mitochondria maintain a greater (i.e., more
negative) DGATP for a given oxygen flux. It must be noted, how-
ever, that in these in vitro assays, DGATP is held constant
(clamped) by large excesses of CK and a defined creatine/
adenylate pool, which together confer unlimited capacitance to
compensate for potential deficits in the rate of mitochondrial
ATP regeneration. For this reason, in the context of our assay,
the precise contributions of JO2 and CK flux to DGATP are un-
known, and therefore we are unable to discriminate between
changes in energy transfer efficiency (i.e., more negative Dp fora given JO2) and/or flux resistance at the level of ATP synthesis
and transport, without additional diagnostics (addressed below).
Mitochondrial JH2O2 Emission Is Greater in Heart Than
Skeletal Muscle and Increases across a Physiologic
Span of ATP Free Energies in Both Tissues
Alterations in respiratory conductance that promote hyper-
reduction of the NAD(P)H/AD(P)+ redox state might favor
electron leak (Quinlan et al., 2012). Because electron leak and
oxidative stress have been implicated as culprits in numerous
pathologies (Kanaan and Harper, 2017), we sought to add further
value to our mitochondrial diagnostics platform by incorporating
measures of JH2O2 emission as a function of ATP free energy.
The rate of electron leak can be determined in isolatedmitochon-
drial by measuring the rate of H2O2 emission using the Amplex
Ultra Red/Horseradish Peroxidase system (Fisher-Wellman
et al., 2013a). Accurate quantification of H2O2 using this system
requires that all substrates/chemicals employed in the protocol
be evaluated for potential interference with resorufin fluores-
cence (Fisher-Wellman et al., 2013a). To this end, H2O2 standard
curves were generated in the presence of each inhibitor/ATP/
PCr combination necessary for the CK clamp technique (Fig-
ure S3A). Slopes calculated from the linear regression of resoru-
fin fluorescence intensity versus H2O2 (in picomoles) were unaf-
fected by auranofin (0.1 mM) and ATP (5 mM), either alone or in
combination, but were depressed with the additional inclusion
of PCr (6 mM) (Figure S3B). To control for this effect, quantifica-
tion of H2O2 within a given experiment was performed using
standard curves unique to each of the substrate/PCr combina-
tions tested. Another important consideration for these assays
is that the observed H2O2 emission rates represent the balance
between ROS generation and scavenging. To gain a better
approximation of absolute H2O2 production rates, the protocol
developed includes auranofin, which inhibits thioredoxin reduc-
tase-mediated scavenging of H2O2 in the mitochondrial matrix
(Fisher-Wellman et al., 2013a; Munro et al., 2016). Importantly,
the concentration of auranofin used in these assays did not
affect respiratory conductance (Figure 5A), but as expected, its
presence increased JH2O2 emission (Figures 5B and 5C). In
these experiments, mitochondria isolated from skeletal muscle
were energized with Pyr/M under state 4 conditions (non-
phosphorylating), and then exposed to increasing ATP free en-
ergies by the addition of PCr. Consistent with previous reports,
JH2O2 emission was greatest during state 4 respiration, and
markedly diminished upon exposure to low ATP free energy
(i.e., near-maximal JO2). Subsequent additions of PCr, resulting
in a more physiologic energy charge (DGATP), progressively
increased JH2O2 (Figures 5B and 5C).
To determine tissue-specific differences in the relationship be-
tween electron leak and DGATP, both JO2 and JH2O2 emission
were measured under identical conditions using the CK clamp
technique applied to isolated mitochondria from skeletal muscle
and heart energized with G/M, Pyr/M, and Oct/M. Because
JH2O2 increases as a function of total electron flux, rates of
electron leak were expressed as a percent of oxygen flux
(JH2O2/JO2) (Figures 5D and 5E). This experiment revealed
near stepwise increases in electron leak in both skeletal muscle
(Figure 5D) and heart (Figure 5E) mitochondria, particularly forCell Reports 24, 3593–3606, September 25, 2018 3599
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Figure 5. Thioredoxin Reductase Inhibition Reveals Stepwise Increases in Electron Leak during Transition from High to Low Energetic
Demands
(A) Relationship between mitochondrial oxygen consumption and ATP free energy (DGATP) in heart mitochondria (0.1 mg/mL) energized with Oct/M performed in
the presence of DMSO or auranofin (AF) (0.1 mM).
(B) Representative trace showing H2O2 emission from skeletal muscle mitochondria energized with Pyr/M under increasing ATP free energies performed in the
absence (AF) or presence (+AF) of AF.
(C) Quantification of the data depicted in (B).
(D and E) Electron leak, expressed as a percentage of total flux (JH2O2/JO2 = % Electron Leak), measured in isolated mitochondria prepared from (D) skeletal
muscle or (E) heart. Mitochondria were energized with G/M, Pyr/M, or Oct/M and assayed under near-state 4 conditions followed by exposure to ATP free
energies of 12.95, 13.95, and 14.49 kcal/mol corresponding to PCr concentrations of 1, 6, and 15 mM.
(F) Difference in absolute JH2O2 emitting potential between skeletal muscle and heart for each experimental condition expressed as linear fold chance (FC)
(Hrt/SkM). Data are mean ± SEM.
Differences between groups were analyzed by Student’s t tests in (C) and (F), and one-way ANOVA with Tukey’s multiple comparison in (D) and (E). *p < 0.05,
**p < 0.001, and ***p < 0.0001. n = 4–7/group, where n represents 4–7 biological replicates (i.e., mitochondrial preparations).the NAD-linked substrate combinations (G/M and Pyr/M). Inter-
estingly, although not apparent under state 4 conditions, relative
rates of fatty acid (Oct/M)-supported electron leak were higher
than all other substrate combinations at each DGATP in skeletal
muscle, and for the lowest (i.e., least negative) DGATP in heart
mitochondria (Figures 5D and 5E). Absolute rates of electron
leak were higher in heart compared to skeletal muscle mitochon-
dria for all conditions assessed, with the exception of Oct/M at a
DGATP of13.95 (kcal/mol) (Figure 5F). These results are consis-
tent with the finding that heart mitochondria generate a greater
DJ for any given rate of oxygen flux (Figures 4E–4G), and pro-
vide evidence that rates of ROS emission under physiological
conditions are sensitive to shifts in substrate supply and energy
demand.
Comprehensive Assessment of Mitochondrial Energy
Transfer and Enzymatic Fluxes Provide Mechanistic
Insights into Tissue-Specific Differences in Respiratory
Conductance
The final arm of this platform involves real-time assessment
of multiple enzyme activities using alamethicin-permeabilized
mitochondria, along with substrate-specific rates of ATP synthe-3600 Cell Reports 24, 3593–3606, September 25, 2018sis measured in intact mitochondria, assayed together in a
single 96-well plate. These assays employ spectrofluorometric
(excitation/emission, 340/450 nm) measures of NADH or NADPH
kinetics to evaluate maximal activities of several NAD-linked
dehydrogenases; including, the pyruvate (PDH), alphaketogluta-
rate (AKGDH), and branched-chain keto acid (BCKDH) dehydro-
genase complexes, glutamate dehydrogenase (GDH), MDH, and
hydroxyacyl-CoA dehydrogenase (HADHA), all of which were
measured in the forward direction (NADH production [JNADH]),
with the exception of HADHA activity (assessed via NADHdegra-
dation) (Figure 6A; representative traces). NADP-linked enzyme
activities (JNADPH) included isocitrate dehydrogenase (IDH2),
malic enzyme (ME), and GDH (Figure 6B; representative traces).
Consistent with previous studies in liver mitochondria (Godinot
and Gautheron, 1971; Ronchi et al., 2016), we found that GDH
can generate NADPH in both skeletal muscle and heart mito-
chondria when ADP is provided (Figure 6C). As expected,
HADHA activity was 2-fold greater in heart compared to skeletal
muscle mitochondria (Figure 6D). Likewise, JNADH from GDH
and the BCKDH complex were also elevated in heart mitochon-
dria (Figure 6E). By contrast, JNADH from PDH and AKGDH





Figure 6. Comprehensive Assessment of Dehydrogenase Activities and ATP Synthase
(A) Representative traces depicting NADH auto-fluorescence during JNADH assays of various dehydrogenase enzymes. Hadha activity is assessed via NADH
oxidation and thus plotted on the right y axis. Mitochondrial concentrations were adjusted to obtain linearity over time: MDH (0.005 mg/mL), PDH, AKGDH, and
Hadha (0.025 mg/mL), GDH (0.15 mg/mL), and BCKDH (0.3 mg/mL).
(B) Representative traces depicting NADPH auto-fluorescence during JNADPH assays of various dehydrogenases. NADPH production fromGDHwas assessed
in the absence (GDH) and presence (GDPADP) of ADP (2 mM). IDH2 is plotted on the right y axis. Mitochondrial concentrations were as follows: IDH2, ME
(0.025 mg/mL), GDH (0.15 mg/mL).
(C) JNADPH from GDH in both skeletal muscle and heart mitochondria recorded in the absence and presence of ADP (2 mM).
(D) HADHA activity in isolated mitochondria prepared from skeletal muscle and heart.
(E) Rates of NADH and NADPH production from all dehydrogenases studies in skeletal muscle and heart mitochondria.
(F) GOT2 activity in mitochondrial lysates from skeletal muscle and heart.
(G) CV activity in mitochondrial lysates prepared from skeletal muscle and heart.
(H) Quantified rates of ATP synthesis (JATP) from skeletal muscle and heart mitochondria energized with G/M, Pyr/M, Oct/M, and Succ/R assayed in the context
of a hexokinase ADP (0.2 mM) clamp.
(I) Relationship between mitochondrial JO2 versus ATP free energies (DGATP) in mitochondria energized with G/M in the absence and presence of 0.6 mM CaCl2
(free Ca+ 500 nM).
(J) Calculated slopes from the data depicted in (I).
(K) Mitochondria JO2 plotted against DJ in the presence of G/M and CaCl2. Data are mean ± SEM. Differences between tissues were analyzed by Student’s
t tests. *p < 0.05, **p < 0.001, and ***p < 0.0001. n = 3–7 individual mice/group.whereas MDH activity was similar between tissues (Figure 6E).
The activities of all NADPH-producing enzymes were greater in
heart compared to skeletal muscle mitochondria (Figure 6E;
JNADPH). Given that JNADPH determines H2O2-scavenging ca-
pacity within the matrix (Cortassa et al., 2014), high activity of
cardiac NADP-linked dehydrogenases might confer protection
against the relatively greater peroxide burden imposed by the
heart mitochondrial program (Figure 5F).Integration of the NAD-linked enzyme activity results (Fig-
ure 6E) and the respiratory conductance phenotypes (Figure 4)
revealed strong agreement across substrate conditions, with
the notable exception of G/M. Thus, the low G/M-supported
conductance in heart mitochondria was not explained by a cor-
responding decline in a relevant dehydrogenase activity.
Although we did observe a slight decrease in AKGDH activity
in heart mitochondria, respiratory conductance in the presenceCell Reports 24, 3593–3606, September 25, 2018 3601
of AKG alone was similar between tissues (Figures S4C and
S4D). Moreover, the primary dehydrogenases activated in the
presence of G/M are MDH and GDH, because high malate con-
centrations tend to deplete matrix AKG via metabolite exchange
(Figure 1B). Under these conditions, maximal MDH flux depends
on the rate at which glutamate oxaloacetate transaminase
(GOT2) can remove oxaloacetate. However, GOT2 activity was
actually 15% higher in heart compared to skeletal muscle
mitochondria (Figure 6F). In aggregate, these discordant results
prompted us to consider limitations in substrate delivery
imposed at the level of glutamate/aspartate exchange. This pro-
cess is carried out via the aspartate/glutamate carriers (AGC),
aralar (SLC25A12) and citrin (SLC25A13), which are known to
be differentially expressed in these two tissues and differentially
sensitive to and activated by extra-mitochondrial calcium
(Contreras et al., 2007; Palmieri et al., 2001). We therefore exam-
ined G/M-supported respiratory conductance in absence and
presence of 0.6 mM CaCl2 (free calcium 500 nM in the pres-
ence of 1 mM EGTA). Strikingly, addition of calcium increased
G/M-supported conductance nearly 4-fold in heart mitochon-
dria, while having little impact in skeletal muscle (Figures 6I
and 6J). The presence of calcium also normalized NAD(P)H/
NAD(P)+ redox between the two pools of mitochondria (Fig-
ure S4E) and led to a relative hyper-polarization of DJ in the
heart (Figure 6K). Plotting JO2 against DJ once again revealed
a rightward shift in heart mitochondria (Figure 6K), identical to
that seen with the other substrate combinations and consistent
with heightened OXPHOS efficiency in the heart.
Last, we sought to determine whether the rightward shift in the
relationship between JO2 and DJ in heart mitochondria (Figures
4E–4G)might reflect increased resistance within the ATP synthe-
sis control node, and/or heightened OXPHOS efficiency. To ac-
count for the former, the assay platform incorporatesmultiple as-
sessments of ATP synthase activity and flux (JATP). The activity
of ATP synthase was assayed in mitochondrial lysates in the
reverse direction (i.e., ATP hydrolysis) in the absence or pres-
ence of oligomycin, which permits subtraction of ATPase activity
not requiring the ATP synthase complex (Figure S5A). Maximal
activity of the ATP synthase complex was similar between skel-
etal muscle and heart mitochondria (Figure 6G). Assessment of
JATP in intact mitochondria (Figure 6H), which depends on
maximal rates of energy transfer through nodes 1–3, revealed
substrate-dependent differences between skeletal muscle and
heart that closely matched the maximal dehydrogenase fluxes.
Interestingly, maximal JATP was similar between the skeletal
muscle and heart (Figure 6H; compare Sk. Muscle G/M and
Pyr/M to Heart Oct/M). Taken together, these findings offer no
evidence that resistance at node 3 is dissimilar between the
two mitochondrial populations, suggesting that the rightward
shift in DJ at any given JO2, observed in heart mitochondria
under all substrate combinations, reflects increased OXPHOS
efficiency that appears to be independent of differences in
proton leak (Figures S5D and S5E).
DISCUSSION
While the advent of ‘‘-omics’’ technologies has spawned an
extraordinary new era of discovery science, challenges and3602 Cell Reports 24, 3593–3606, September 25, 2018limitations pertaining to data interpretation are increasingly
recognized as a potential pitfall and source of misinformation.
Inarguably, unbiased analyses of SNPs, transcripts, proteins,
post-translational modifications, and metabolites offer great po-
tential to identify molecular signatures of health and disease, but
the biological relevance and clinical implications of those signa-
tures cannot be clearly understood without similarly comprehen-
sive approaches for phenotyping of cellular and/or organelle
function. To address this important methodological gap, we
developed amitochondrial diagnostics platform for deep pheno-
typing of respiratory fluxes and function at a level that is highly
complementary to most molecular -omics tools. The assay plat-
form can be integrated with other high-throughput technologies
to facilitate functional phenomics of the same pool of mitochon-
dria or tissue specimens used for unbiased molecular analyses,
greatly enhancing the interpretive power of the science. Using
the specified instrumentation and workflow, the entire collection
of assays described herein can be performed in isolated mito-
chondria from a single mouse, and expanded to accommodate
approximately four mice per day, depending on logistical con-
straints. Assuming a mitochondrial yield of >1.5 mg/tissue, the
final mitochondrial pellet can be subdivided into 23 aliquots
dedicated to functional (1 mg) and other molecular analyses
(0.5 mg). Comprehensive mitochondrial flux assessments
can then be informed by concurrent molecular phenomics
assays, and vice versa, to produce high-confidence candidate
targets for follow-up investigation.
Aswithother biological andphysiological outcomesmeasures,
capturing dynamic respiratory responses to energy challenge
can be much more revealing than a static snapshot. Thus, the
key element of the platform described here is a CK energetic
clamp technique that enables a highly tractable in vitro system
for assessing respiratory sensitivity and resistance to dynamic
energetic conditions. Importantly,we have adapted theCKassay
as originally described (Glancy et al., 2013;Messer et al., 2004) to
optimize the buffer conditions (Figure S1) and accommodate
high-throughput analysis, which permits multiplexing of sub-
strate conditions. The workflow developed includes measure-
ments of respiratory conductance,DJ, NAD(P)H/NAD(P)+ redox,
and JH2O2 emission across a physiologic span of ATP free en-
ergies, combined with parallel assessments of multiple dehydro-
genaseactivities andATPsynthetic capacity, all performed in real
time. The comprehensive nature of the platform not only allows
for an estimation of relative conductance throughout the respira-
tory system but also pinpoints potential sites of flux resistance
within the three major control nodes. To aid data interpretation,
we provide a diagnostics tree (Figure 7) that predicts likely sites
of differential regulation based on the collective respiratory phe-
notypes of two discordant mitochondrial populations.
To demonstrate the diagnostic utility of the assay platform, we
sought to characterize and decipher functional distinctions be-
tween mitochondria resident in mouse skeletal muscle tissue
as compared to those derived from the heart. The results re-
vealed insights into the unique programming and/or organization
of these two mitochondrial populations. Interestingly, OXPHOS
conductance in heart mitochondria was higher in the presence
of FAD-linked substrates (Oct/M and Succ/R), but surprisingly
lower in the presence of NAD-linked fuels (Pyr/M and G/M).
Figure 7. Mitochondrial Diagnostics Tree
Diagram summarizing how this functional assay
platform can be used to diagnose distinct sites of
resistance within the mitochondrial energy trans-
duction pathway. Primary respiratory phenotypes
are depicted in the gray-filled ovals. Listed below
each phenotype are candidate sites of regulation
and potential strategies for validation, assuming
Pyr/M was the substrate. Expected diagnostic
results for several common respiratory inhibitors
are listed.The contrast between the two populations of mitochondria
was most remarkable when respiration was supported by either
G/M or Oct/M, both which produced a 4-fold tissue-specific
difference in conductance, but in opposite directions, with the
heart strongly preferring Oct/M. In these experiments, a fall in
conductance was universally associated with less polarized
DJ and less reducedNAD(P)H/NAD(P)+ redox, thereby revealing
lower steady-state free energies generated by nodes 1 and 2.
As depicted by the diagnostic tree diagram (Figure 7),
the phenotype of ‘‘Decreased’’ Respiratory Conductance /
‘‘Depolarized’’DJ/ ‘‘Oxidized’’ NAD(P)H/NAD(P)+ redox state,
predicts OXPHOS resistance at control node 1 (‘‘Matrix Dehy-
drogenases’’). This interpretation was subsequently validated
for the fatty-acid substrate combination by the dehydrogenase
assay module (Figure 6D).
Whereas mouse heart mitochondria are known to have high
capacity to oxidize fatty acids (Fisher-Wellman et al., 2013b),
the dramatic fall in respiratory conductance when the fuel source
switched to G/M was unanticipated. In sum, the findings sug-
gested that G/M-supported flux in mitochondria from mouse
heart was limited by resistance at node 1. Because comprehen-
sive assessment of enzyme activities linked to glutamate flux
failed to identify an enzymatic explanation for the dramatic differ-
ences in G/M-supported respiratory conductance, we reasoned
that this phenotype might be driven by differences in metabolite
transport. Indeed, subsequent experiments revealed that
G/M-supported conductance in heart mitochondria is highly
dependent on extra-mitochondrial calcium. Given that previous
studies have shown that aspartate/glutamate transport in heart
mitochondria is activated by calcium (Contreras et al., 2007),
we surmise that the G/M-supported respiratory phenotypes
observed herein are mediated by tissue-specific expressionCell Reportsand/or regulation of the two distinct iso-
forms of the AGC. Because the AGC is a
key component of the malate-aspartate
shuttle, which transfers redox equivalents
from the cytoplasm to the mitochondrial
matrix, these findings raise intriguing
possibilities regarding the potential role
of this carrier in the setting of heart failure
and other pathologies linked to impaired
calcium signaling (Carley et al., 2014; Fin-
kel et al., 2015).
Irrespective of substrate conditions,
maximal respiratory conductance was10% lower in mitochondria from heart (max conductance
with Oct/M) compared to skeletal muscle (max conductance
with Pyr/M or G/M). Similarly, maximal flux measurements of
the most robust NAD-linked dehydrogenases (AKGDH and
PDH) were also 10%–50% lower in heart mitochondria. Thus,
skeletal muscle mitochondria have superior OXPHOS flux ca-
pacity and sensitivity, driven primarily by more robust dehydro-
genase enzyme kinetics, and therefore appear better poised to
respond to a sudden and dramatic discharge of DGATP during
the transition from rest to intense exercise. Measurements of
maximal JO2 and/or JATP in isolationmight lead one to conclude
that heart mitochondria are surprisingly inferior. However, when
results from the entire assay platform are synthesized, new in-
sights emerge. For example, although maximal JO2 was lower
in heart compared to skeletal muscle mitochondria, when as-
sayed under more physiologically relevant energetic states
(greater ATP free energy), heart mitochondria were able to main-
tain a greater (more negative) steady-state DJ for any given rate
of JO2, as compared to skeletal muscle mitochondria working
against the same energy charge and fueled by the same carbon
substrates. Here, it is important to underscore that, in vivo, the
capacity of the oxidative system to maintain or ‘‘recharge’’ the
DGATP battery during elevated work rates is determined largely
by the Dp charge (the exception being a state of CV/ANT inhibi-
tion). Thus, whereas JO2 provides a measure of energy demand,
Dp (or DJ) is a better indicator of DGATP. A drop in steady-state
Dp lowers the driving force to displace the ATP/ADP ratio from
equilibrium, thus diminishing DGATP and weakening the energy
released by hydrolysis of each ATP molecule, which in turn
threatens metabolic and functional homeostasis. By contrast,
maintenance of a higherDJ for any given JO2 and JATP equates
to an elevated driving force to maintain DGATP, and thus24, 3593–3606, September 25, 2018 3603
increased aerobic power to sustain energetic stability in the face
of a highwork rate.When taken together, our results suggest that
heart mitochondria are uniquely programmed to defend DGATP
across a physiologic span of energetic demands, which appears
attributable to some combination of heightened efficacy of en-
ergy transfer within the ETS and/or differences in CV/ANT-inde-
pendent consumption of the proton current. These findings
strongly agree with the known ability of healthy working hearts
to maintain steady-state concentrations of adenylates (e.g.,
ATP, ADP) and NADH/NAD+ redox charge across a span of
increasing workloads (Balaban et al., 1986; Heineman and Bala-
ban, 1990). Increased OXPHOS efficiency could prove advanta-
geous in mouse cardiac tissue, which maintains a resting heart
rate of 500—600 beats/min and therefore must defend the
ATP free energy charge within a narrow range of consistently
high metabolic demands. The biological trade-off for increased
efficiency appears to be a relatively lower OXPHOS elasticity
along with heighted electron leak, as demonstrated herein by
the elevated JH2O2 emitting potential observed in heart versus
muscle mitochondria. In the context of a healthy heart, such
trade-offs might be counterbalanced by increased JNADPH
flux, which is expected to mitigate potential toxicities imposed
by a heavy peroxide load. By contrast, when confronted with
pathophysiological insults such as ischemia-reperfusion, the
phenotype of heart mitochondria might present unique vulnera-
bilities to oxidative stress.
In sum, this work provides a manual for building and operating
a diagnostics tool kit designed to facilitate deep phenotyping
of mitochondrial energy transduction and respiratory function.
Application of this platform to a comparison of mitochondrial
populations derived from skeletal muscle and heart uncovered
discordant respiratory phenotypes mediated by each of the
three regulatory nodes highlighted in Figure 1, which in turn pro-
vided provocative insights into the link between tissue-specific
mitochondrial programming and function. The suite of assays
described here is meant to serve as a base platform, upon which
new modules can be added and/or tailored to expand coverage
and/or meet specific research needs. Inclusion of additional
substrate combinations that broaden the scope of the meta-
bolic network engaged by respiring mitochondria would surely
strengthen the diagnostics value of the platform. When com-
bined with other ‘‘shotgun’’ -omics technologies, this respiratory
phenomics workflow now presents exciting opportunities for
discovering novel biology and disentangling mechanisms of
pathophysiology and disease.STAR+METHODS
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STAR+METHODSKEY RESOURCES TABLEREAGENT or RESOURCE SOURCE IDENTIFIER
Antibodies
Total Rodent OXPHOS WB Antibody Cocktail Abcam Cat# ab110413; RRID: AB_2629281
Chemicals, Peptides, and Recombinant Proteins
Tris salt of phosphocreatine Millipore Sigma Cat# P1937
CAS# 108321-17-1
Tris salt of ATP Millipore Sigma Cat# A9062
CAS# 102047-34-7
Potassium pyruvate Combi-Blocks Cat# QA-1116
CAS# 4151-33-1
Potassium NADP+ Ark-Pharm, Inc Cat# AK671068
Creatine kinase from rabbit muscle Millipore Sigma Cat# 10736988001
Percoll solution Millipore Sigma Cat# P1937
CAS#108321-17-1
Amplex Ultra Red Reagent (AUR) ThermoFisher Scientific Cat# A36006
CelLytic M Millipore Sigma Cat# C2978
Tetramethylrhodamine methyl ester (TMRM) ThermoFisher Scientific Cat# T668
Phosphoenoyl-pyruvate Millipore Sigma Cat# 10108294001;
CAS# 4265-07-0
UK5099 Millipore Sigma Cat# PZ0160;
CAS# 56396-35-1
Auranofin Millipore Sigma Cat# A6733;
P1,P5-Di(adenosine-50)pentaphosphate Millipore Sigma Cat# D6392;
CAS# 75522-97-3
Oligomycin Millipore Sigma Cat# 75351
CAS# 579-13-5
Rotenone Millipore Sigma Cat# R8875
CAS# 83-79-4
Potassium cyanide Millipore Sigma Cat# 60178
CAS# 151-50-8
Carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP) Millipore Sigma Cat# C2920
CAS# 370-86-5
Peroxidase from horseradish (HRP) Millipore Sigma Cat# P8375
CAS# 9003-99-0
Superoxide dismutase (SOD) Millipore Sigma Cat# S9697
CAS# 9054-89-1
Glucose-6-phosphate Dehydrogenase (G6PDH) Millipore Sigma Cat# G6378
CAS# 9001-40-5
Malate dehydrogenase (MDH) Millipore Sigma Cat# 442610-M
CAS# 9001-64-3
Pyruvate Kinase/Lactic Dehydrogenase enzymes from rabbit muscle Millipore Sigma Cat# P0294
Hexokinase Millipore Sigma Cat# H4502
CAS# 9002-07-7
Trypsin from porcine pancreas (Trypsin) Millipore Sigma Cat# T4799
CAS# 9001-51-8
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REAGENT or RESOURCE SOURCE IDENTIFIER
Creatine Monohydrate Millipore Sigma Cat# C3630
CAS# 6020-87-7
Octanoyl-L-carnitine Millipore Sigma Cat# 50892
CAS# 25243-95-2
Malic acid (Malate) Millipore Sigma Cat# M1000
CAS# 97-67-6
Glutamic acid (Glutamate) Millipore Sigma Cat# G1501
CAS# 6382-01-0
Succinic acid (Succinate) Millipore Sigma Cat# S3674
CAS# 110-15-6
a-ketoglutaric acid (AKG) Millipore Sigma Cat# K1750
CAS# 328-50-7
3-Methyl-2-oxopentanoic acid (a-keto-b-methylvalerate) Millipore Sigma Cat#198978;
CAS#3715-31-9
Isocitrate Millipore Sigma Cat#58790;
CAS#20226-99-7
Adenosine diphosphate (ADP) Millipore Sigma Cat# A5285
CAS# 72696-48-1
Tetraphenylphosphonium (TPP+) Millipore Sigma Cat# 218790
CAS# 2001-45-8
NADH Millipore Sigma Cat# N4505
CAS# 104809-32-7
Nicotinamide adenine dinucleotide (NAD+) Millipore Sigma Cat# N1636
CAS# 53-84-9
L-Aspartic acid (Aspartate) Millipore Sigma Cat# A9256
CAS# 56-84-8
Acetoacetyl-CoA Millipore Sigma Cat# A1625
CAS# 1420-36-6
Coenzyme A Millipore Sigma Cat# C3019
CAS# 18439-24-2
Thiamine pyrophosphate Millipore Sigma Cat# C8754
CAS# 154-87-0
Pyridoxal 50-phosphate Millipore Sigma Cat# P9255
CAS# 853645-22-4
Experimental Models: Organisms/Strains
C56BL/6NJ mice The Jackson Laboratory Stock #005304
Software and Algorithms
Jupyter notebook containing the adjustment calculations interspersed




Web-based DGATP calculator N/A https://dmpio.github.io/bioenergetic-
calculators/ck_clamp/
Other
Ultracentrifuge tubes for mitochondrial percoll purifications Beckman Coulter Cat# 344061
Swinging bucket ultracentrifuge rotor for mitochondrial percoll
purifications – Surespin 630 with tube adapters
ThermoFisher Scientific Cat# 79363
QuantaMaster Spectrofluorometer Horiba Scientific Cat# QM-400
e2 Cell Reports 24, 3593–3606.e1–e10, September 25, 2018
CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Deborah
Muoio (debbie.muoio@duke.edu).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
All animal studies were approved by the Duke University Institutional Animal Care and Use Committee. Male C57BL/6NJ (Stock
#005304)mice were purchased from Jackson Laboratory as littermates at 8 weeks of age. All experiments were carried out on
mice between the ages of 8-12 weeks. All mice were housed in a temperature (22C) and light controlled (12 hour light/12 hour
dark) room and given free access to food and water. Unless otherwise stated, mice were fasted 1 hour, anesthetized with Nembutal
(intraperitoneal injection; 40mg/kg), and the following tissues were removed for mitochondrial isolation and subsequent functional
analysis: skeletal muscle (gastrocnemius, plantaris, soleus, quadriceps) and heart (complete left and right ventricles).
METHOD DETAILS
Chemical & Reagents
Unless otherwise stated, all chemicals were purchased from Sigma-Aldrich. Tris salts of phosphocreatine (P1937) and ATP (A9062)
were purchased from Sigma-Aldrich. Potassium pyruvate was purchased from Combi-Blocks (QA-1116). Potassium NADP+ was
purchased from Ark-Pharm (AK671068). Amplex Ultra Red (A36006), and Tetramethylrhodamine methyl ester (TMRM; T668) were
purchased from Thermo Fisher Scientific. Creatine kinase (CK-RO) from rabbit muscle was purchased from Roche Life Science.
Mitochondrial Isolation
Differential centrifugation was employed to prepare isolatedmitochondria from skeletal muscle and heart. The following buffers were
utilized for all isolations: Buffer A – (phosphate buffered saline (pH = 7.4), supplemented with EDTA (10mM); Buffer B –MOPS (50mM;
pH = 7.1), KCl (100mM), EGTA (1mM), MgSO4 (5mM); Buffer C – Buffer B, supplemented with bovine serum albumin (BSA; 2g/L).
Skeletal muscle and heart were excised and immediately placed in ice-cold Buffer A. All tissues were minced and subjected to a
5-minute incubation on ice in Buffer A, supplemented with 0.025% trypsin. Following trypsin incubation, skeletal muscle and heart
suspensionswere centrifuged at 200 X g for 5-minutes at 4C to remove trypsin. Tissue pellets were resuspended in Buffer C and then
homogenized via a Teflon pestle and boroscilicate glass vessel. Tissue homogenates were centrifuged at 500 x g for 10-minutes at
4C. Supernatant from each tissue was then filtered through thin layers of gauze and subjected to an additional centrifugation at
10,000 x G for 10-minutes at 4C. Mitochondrial pellets were washed in 1.4ml of Buffer B, transferred to microcentrifuge tubes
and centrifuged at 10,000 x g for 10-minutes at 4C. Buffer B was aspirated from each tube and final mitochondrial pellets were sus-
pended in 100-200 mL of Buffer B. Protein content was determined via the Pierce BCA protein assay. Functional assays involving
isolated mitochondria were carried out in the following buffers; Buffer D – Potassium-MES (105mM; pH = 7.2), KCl (30mM),
KH2PO4 (10mM), MgCl2 (5mM), EGTA (1mM), BSA (2.5g/L); Buffer E – HEPES (20mM; pH = 8.0), KCl (100mM), KH2PO4 (2.5mM),
MgCl2 (2.5mM), Glycerol (1%).
Mitochondrial purification with Percoll
Mitochondrial Percoll purification was carried out as previously described (Glancy and Balaban, 2011; Graham, 2001), with some
modifications. Mitochondrial pellets (5mgs) were resuspended in 1ml of sucrose wash buffer (250mM sucrose, 10mM HEPES
(pH = 7.2), 0.1% BSA). A 30% percoll solution was prepared by mixing sucrose wash buffer with Percoll solution (Sigma: P4937)
and adjusting the pH to 7.2. Self-generating percoll gradients were prepared by adding 15ml of the 30% Percoll solution to ultracen-
trifuge tubes (Beckman: #344061) and then layering the mitochondrial suspensions atop using a plastic transfer pipette. Samples
were centrifuged in a swinging bucket ultracentrifuge rotor (ThermoFisher Scientific Cat #79363) at 22,700 RPM for 20 minutes at
4C. This process yielded two distinct bands containing a top unpurified fraction and a bottom purified mitochondrial fraction.
Purified mitochondria were extracted using a plastic transfer pipette and immediately washed in 40ml of sucrose wash buffer.
Following centrifugation at 10,000 x g for 10-minutes at 4C, mitochondrial pellets were washed once more in Buffer B prior to final
resuspension in Buffer. Protein content was determined using the Pierce BCA assay.
Preparation of mouse mitochondrial pellets for western blotting
Flash frozen isolated mitochondrial pellets from each tissue were thawed on ice and homogenized in CelLytic M (Sigma-Aldrich)
supplemented with protease inhibitor cocktail using a motor-drive Potter-Elvehjem tissue grinder. Samples were centrifuged at
14,000 x g for 10min at 4Cand the supernatant saved and frozen at80Cuntil later analysis. Protein concentrationwas determined
via the Pierce BCA assay and the samples were diluted in CelLytic M. Forty micrograms of protein sample were combined with
5x loading buffer and resolved by SDS-PAGE, transferred to nitrocellulose, blocked for1 hr in 5%Milk prepared with TBS followed
by western blotting with specific antibodies. Antibodies employed herein were: OXPHOS cocktail (Abcam: #ab110413).Cell Reports 24, 3593–3606.e1–e10, September 25, 2018 e3
Mitochondrial Respiratory Control
High-resolution O2 consumption measurements were conducted using the Oroboros Oxygraph-2K (Oroboros Instruments). All ex-
periments were carried out at 37C in a 2ml reaction volume. Steady-state oxygen consumption rates (JO2) ranging from near resting
up to95%ofmaximal were sequentially determined within individual experiments using amodified version of the creatine energetic
clamp technique (Glancy et al., 2013; Messer et al., 2004). In this assay, the free energy of ATP hydrolysis (DG’ATP) can be calculated
based on known amounts of creatine (Cr), phosphocreatine (PCr) and ATP in combination with excess amounts of creatine kinase










where DG’ATP is the standard apparent transformed Gibbs energy (under a specified pH, ionic strength, free magnesium and
pressure), R is the gas constant (8.3145 J/kmol) and T is temperature in kelvin (310.15). Given that experiments were performed
via sequential additions phosphocreatine, both the DG’ATP and K’CK were determined at each titration step based on the changes
in buffer ionic strength and free magnesium, as previously described (Golding et al., 1995; Teague et al., 1996). For complete details
regarding the calculation of DG’ATP at each titration point see the ‘‘ADDITIONAL RESOURCES’’ section below.
Buffer for all assays was Buffer D, supplemented with ATP (5mM), creatine (Cr; 5mM), phosphocreatine (PCr; 1mM) and creatine
kinase (CK; 20U/ml). To begin, isolatedmitochondria (0.025mg/ml) were added to assay buffer, followed by the addition of respiratory
substrates. The following substrate conditions were tested: [Octanoyl-carnitine/Malate – (Oct/M; 0.2/2.5mM), Glutamate/Malate –
(G/M; 10/2.5mM), Pyruvate/Malate – (Pyr/M; 5/2.5mM), Succinate/Rotenone – (Succ/R; 10/0.005mM)]. Following substrate addi-
tions, sequential additions of PCr to 3, 6, 9,12, 15, 18, 21, 24, 30mM were performed to gradually reduce JO2 back toward baseline.
For experiments in which a state 4 (i.e., non-phosphorylating) respiration rate were determined, ATP was omitted from the initial
buffer and added after the addition of respiratory substrates. Plotting the calculated DG’ATP against the corresponding JO2 reveals
a linear force-flow relationship, the slope of which represents the conductance/elasticity of the entire respiratory system under spec-
ified substrate constraints.
Importantly, the foregoing working model of respiratory conductance assumes that the ATP synthetic complexes (ATP synthase
(CV) and the adenine nucleotide translocase; ANT) are the sole resistors through which the proton current flows (Glancy et al., 2013),
which also implies that buffer components other than carbon substrates do not impact JO2 in a CV-independent manner. Contrary to
this assumption, preliminary experiments revealed that the presence of Na+ ions (supplied via NaCl) resulted in a 25% increase in
maximal ADP-stimulated JO2 in skeletal musclemitochondria (Figures S1A and S1B). Given that this increase in JO2was notmet by a
comparable increase in maximal JATP synthesis (Figure S1C), it was hypothesized that the presence of Na+ ions activated a futile
pathway of oxygen consumption. The most commonly available commercial sources of phosphocreatine and ATP are di-sodium
salts. We further hypothesized that the use of these salts in the assessment of mitochondrial respiratory conductance might violate
the critical assumption detailed above, thereby precluding accurate determination of OXPHOS conductance. To test this hypothesis,
force-flow experiments were performed in isolated mitochondria from both skeletal muscle and heart mitochondria, energized with
G/M (Figure S1D) and Oct/M (Figure S1E), respectively. For these experiments, the CK clamp was established using ATP and phos-
phocreatine supplied as either di-sodium or di-tris salts. Once again, absolute rates of JO2 were higher in the presence of sodium
compared to tris salts (Figures S1D and S1E); however, the slopes of the relationship between JO2 and DGATP were greater in the
presence of tris compared to sodium-salts in both tissues (Figure S1F). These findings strongly suggest that the heightened JO2
observed in the presence of Na+ ions does not contribute to ATP synthesis.
With respect to the source of the increase in JO2 in the presence of Na
+, the mechanism likely arises from the activation of
Ca2+/3Na+ exchange at the inner mitochondrial, which along with concurrent Na+/H+ exchange promotes matrix Ca2+ depletion in
a process driven by the Dp (Territo et al., 2001). Activation of this cycling pathway would increase respiratory flux without providing
any additional ATP flux and as such could explain the lower respiratory conductance observed in the presence of Na+ salts.
Additionally, the impact of matrix calcium depletion must also be considered. Although most well-known for its role in activating
several matrix dehydrogenases (PDH, AKDH and IDH) (McCormack and Denton, 1980), free calcium in the matrix has recently
been demonstrated to enhance electron conductance within the ETS and promote the increased activity of the ATP synthase com-
plex (Glancy et al., 2013). Thus, impairments in ETS efficiency and ATP synthase capacity could also account for the lower respiratory
conductance observed in the presence Na+ compared to Tris-salts. In addition, Na+-dependent oxygen flux could arise secondary to
the use of trypsin/EDTA in themitochondrial preparation, as removal ofMg2+ can impactmembrane integrity [2] and proteolysis of the
mitochondrial calcium uniporter has recently been shown induce leak conductance [3,4]. To directly test this, phosphocreatine titra-
tion experiments employing either Na+ or Tris+ salts were repeated in isolated mitochondrial prepared from heart tissues without the
use of trypsin or EDTA. Similar to that seen in the previous experiments (Figures S1D–S1F), the presence of Na+ increased absolute
JO2 at each ATP free energy and tended to lower respiratory conductance compared to the use of Tris
+ salts (Figures S1G and S1H).
Regardless of the mechanism and in order to satisfy the critical assumption of the CK energetic clamp detailed above, sodium-salts
were avoided for all experiments.e4 Cell Reports 24, 3593–3606.e1–e10, September 25, 2018
Assay Rationale
Traditional respirometry involves the assessment of mitochondrial JO2 capacity via the addition of ADP, either in bolus amounts (e.g.,
no ADP ‘‘state 4’’ versus 5mM ADP ‘‘state 3’’) or in submaximal clamped titrations (e.g., hexokinase ADP clamp technique). In either
case, respiratory flux is stimulated exclusively via ADP. Such conditions differ dramatically from those present in vivo whereby mito-
chondrial flux rates respond to alterations in the free energy of ATP hydrolysis (DG’ATP), which itself exists as the ‘‘back-pressure’’ in
living systems preventing unabatedmetabolic flux. A total collapse inDG’ATP (i.e., excess amounts of ADP) would eliminate the ability
of ATP to carry out cellular work and as such would exist only in non-living systems. The creatine kinase clamp technique bypasses
the need for bolus ADP to stimulate respiration and in turn does so via manipulation of the extra-mitochondrial ATP/ADP ratio and,
thus, free energy of ATP hydrolysis. This system better mimics physiologic constraints and allows for an estimation of respiratory
conductance/elasticity throughout the OXPHOS system based on a linear force:flow relationship (e.g., Ohm’s Law; I = V/R). In
this equation, current (i.e., flow; I) is respiratory flux, net driving force (V) is the difference between two free energies (i.e., DG’ATP)
and conductance is the reciprocal of resistance (R). By plotting mitochondrial JO2 against the DG’ATP the resulting slope represents
the conductance and/or elasticity of the respiratory system under defined substrate conditions. A change in respiratory conductance
implies that resistance has either been increased (depressed slope) or decreased (increased slope) at some point or points within the
OXPHOS system. The general source of resistance can then be interrogated by measuring the mitochondrial membrane potential
and NAD(P)H/NAD(P)+ redox state under identical conditions. For example, a decrease in respiratory conductance (i.e., depressed
slope) in the presence of no change or hyperpolarization of the mitochondrial membrane potential suggests that the source of resis-
tance driving the change in respiratory conductance likely exists within the ATP synthesis step. Likewise, a decrease in respiratory
conductance (i.e., depressed slope) in the presence of a depolarized mitochondrial membrane potential suggests that the source of
resistance lies within the proton pumps of the electron transport system (e.g., CI, CIII, CIV) and/or the dehydrogenase enzymes
responsible for generating the reducing charge. In the latter scenario, the contribution of the dehydrogenases can be accounted
for by assessing the NAD(P)H/NAD(P)+ redox state (no change or hyper-reduction suggest the proton pumps are the source of resis-
tance, whereas an oxidation of the redox state suggests the dehydrogenase are impaired). In essence, by assessing mitochondrial
JO2, membrane potential (DJ) and NAD(P)H/NAD(P)+ redox state in parallel under defined energetic demands, it becomes possible
to determine global alterations in OXPHOS conductance/elasticity and subsequently assign the location of the source of altered
conductance into one of three control nodes [e.g., 1) Matrix Dehydrogenases, 2) Electron Transport System and 3) ATP synthesis].
Mitochondrial membrane potential (DJ) and NAD(P)H/NAD(P)+ Redox
Fluorescent determination of DJ and NAD(P)H/NAD(P)+ were carried out simultaneously via a QuantaMaster Spectrofluorometer
(QM-400; Horiba Scientific). Determination of DJ via TMRM was done as described previously (Scaduto and Grotyohann, 1999),
taking the fluorescence ratio of the following excitation/emission parameters [Ex/Em, (572/590)/(551/590)]. The concentration of
TMRM employed in our assays did not affect respiratory conductance (Figure S2A). Consistent with previous reports (Scaduto
and Grotyohann, 1999), TMRM uptake into energized mitochondria resulted in fluorescent quenching and shifts in the excitation
and emission spectra (Figure S2B). Comparing the excitation spectra obtained in the presence and absence of FCCP, a respiratory
uncoupler that depolarizes DJ, revealed maximal differences at wavelengths of 551 and 572 nm (Figure S2C). These values were
subsequently utilized as parallel excitation wavelengths, with emission recorded at 590 nm. Figure S1D depicts changes in
TMRMemission intensities, following excitation at both 551 and 572 nmduring a typical CK clamp assay. In this experiment, de-ener-
gized heart mitochondria were assessed in the presence of minimal ATP free energy (13.6 kcals/mol), followed by the addition of
respiratory substrates (Oct/M). Once mitochondria were energized with Oct/M, mitochondrial DJ became hyperpolarized (i.e., more
negative), reflected by a decrease in TMRM emission intensity after excitation at 551 nm. Sequential increases in ATP free energy via
PCr additions further polarized theDJ, whichwas then depolarized at the completion of the experiment via addition of the complex IV
inhibitor, cyanide. Plotting the ratio of the emission intensities recorded following excitation at both 551 and 572 nm increased the
magnitude of changes in TMRM fluorescence above a single excitation/emission protocol (i.e., using 551/590 or 572/590 and
was thus utilized for all experiments moving forward (Figure S2E). The 572/551 ratio was then converted to millivolts via a KCl
standard curve performed in the presence of valinomycin as described by (Krumschnabel et al., 2014). In this protocol, isolated
mitochondria energized with Succ/Rot were incubated in a potassium-free buffer in the presence of valinomycin, a potassium-
specific ionophore. Assuming amatrix potassium concentration of 120mM, DJ can be reasonably estimated by applying the Nernst
equation and buffer ion concentrations resulting from sequential additions of KCl (Krumschnabel et al., 2014). Figure S2F depicts
the 572/551 ratio over time as DJ was varied from 155mV to 102mV via increasing concentrations of KCl. This protocol allowed
for an approximation of DJ via the generation of a calibration curve in which the 572/551 ratio was plotted against the calculated
DJ at each titration step (Figure S2G). While the KCl titration experiments in the presence of valinomycin allow for mitochondrial
DJ quantification, it should be noted that the resulting absolute voltages should be regarded as approximations. Such calculations
are of course only as accurate as the inherent assumptions, which for TMRMbasedDJ-quantification include: 1) equal mitochondrial
protein content between groups and 2) a matrix potassium concentration of 120mM. To validate this approach, TMRM-based
DJ-quantification was compared against parallel assessment of DJ using a tetraphenylphosphonium (TPP+) selective electrode
performed with isolated skeletal muscle mitochondria energized with Pyr/M (Figures S2H–S2J). Although the two methods resulted
in slight differences in absolute mV calculations (Figure S2I), the change in voltage across the assays were identical (10 mVs;
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NAD(P)H excitation/emission parameters were 340/450. All experiments were carried out at 37C in a 0.2ml reaction volume. Buffer
for all assays was Buffer D, supplemented with creatine (Cr; 5mM), phosphocreatine (PCr; 1mM), creatine kinase (CK; 20U/ml) and
TMRM (0.2 mM). To begin, isolated mitochondria (0.1mg/ml) were added to the assay buffer, followed by the addition of respiratory
substrates (Oct/M, G/M, Pyr/M, Succ/R), ATP (5mM), and then sequential PCr additions to a final of 3, 6, 9,12, 15, 18, 21, 24, 30mM.
Following the final PCr addition, cyanide (4mM) was added to induce a state of 100% reduction within the NAD(P)H/NAD(P)+ couple.
The fluorescence (Ex/Em, 340/450) signal recorded in the presence of mitochondria alone without respiratory substrates was used
as the 0% reduction state for the NAD(P)H/NAD(P)+ couple. NAD(P)H/NAD(P)+ during the entire experiment was expressed as a
percentage reduction according to the following formula: % Reduction = (F-F0%)/(F100%-F0%)*100.
Assay Rationale
In this assay, mitochondrial membrane potential is assessed using the cationic fluorophore TMRM. The positive charge carried by
TMRMallows it to equilibrate with the negativemembrane potential generated across the innermitochondrial membrane in energized
mitochondria according to the Nernst equation. Accumulation of TMRM within energized mitochondria results in fluorescence
quenching, as well as spectral shift of 20nM. This spectral shift is utilized to approximate mitochondrial membrane potential. Spe-
cifically, TMRM is excited at both 572nM and 551nM (emission settings are 590nM) and the ratio of 572:590/551:590 is then con-
verted to a mV value using a standard curve assay protocol (see below). The use of the 572:590/551:590 ratio increases the dynamic
range of the assay and allows for more accurate quantification/comparison between experiments. The standard curve protocol in-
volves measuring the TMRM fluorescence ratio under defined membrane potentials. Membrane potential is determined by incu-
bating isolated mitochondria in a buffer devoid of potassium and then subsequently titrating in KCl in the presence of valinomycin
(40ng/ml), which is a highly selective ionophore specific for potassium. The matrix potassium concentration for these assays is
assumed to be 120mM. Since valinomycin allows for any added KCl in the buffer to equilibrate with the matrix potassium, a mem-
brane potential (expressed in mV) can be reasonably calculated according to the Nernst equation (mV = (RT/zF*ln[K+buffer]/[K
+
matrix]).
As mentioned, the mitochondrial isolation buffer for these standard curve assays contains no potassium (250mM Sucrose, 20mM
HEPES, 0.5mM EGTA, pH = 7.2). The assay buffer also contains no potassium (250mM sucrose, 10mM HEPES, 0.2mM EGTA,
2mM NaH2PO4, 1mM MgCl2, 10mM Na-succinate, pH = 7.1). The decision to use TMRM as our experimental tool for assessing
DJwas chosen based on its ability to be easily incorporated intomultiplexed platforms and its relative ease of use for non-mitochon-
drial scientists with respect to a TPP+ electrode. Although determination of DJ with TPP+ in conjunction with a TPP-selective
electrode provides for highly accurate DJ quantification, the temporal restriction imposed by the necessary probe cleaning and cali-
bration procedures required before, as well as between each experimental run limits its amenability to high throughput platforms.
Mitochondrial membrane potential (DJ) using a TPP+ selective electrode
Membrane potential wasmeasured using the OROBOROSOxygraph-2k (Oroboros Instruments) combined with electrodes sensitive
to TPP+ and oxygen at 37C in a 2 mL volume, as previously described (Gilliam et al., 2013). All experiments were run in Buffer D
containing 20U/ml CK, 5 mM creatine, 5mM Na-ATP, 1mM Na-phosphocreatine, 5mM Na-pyruvate, 2.5mM malate and 1.1 mM
TPP+. During the protocol the TPP+ electrode was calibrated by a 6-point titration (1.1-1.35 mM TPP+) for quantifying the concentra-
tion of TPP+. Isolated skeletal muscle mitochondria (0.075mg/ml) were added and rGATP was manipulated by Na-phosphocreatine
titration from a starting concentration of 1mM to 6, 9 and 15mM. The calculation of DJ is based on the Nernst equation with internal/
external binding correction factors and estimates of mitochondrial volume. The Oroboros TPP+-DJ calculation template (http://wiki.




,lnð naddcext;free  Vext  K 0o, Pmt
VmtðspecÞ, Pmt + K 0i , Pmt
Þ
Variables and constants of the equation include: nadd = total amount of ions added to the system; cext,free = free concentration of TPP
+
outside mitochondria; Vext = volume of the external solution outside mitochondria; Vmt = volume of the mitochondrial matrix (1 ml/mg)
(Labajova et al., 2006); Ki’ = internal partition coefficient of TPP
+(11 ml/mg) (Labajova et al., 2006); Ko’ = external partition coefficient of
TPP+(11 ml/mg) (Labajova et al., 2006); Pmt = total mitochondria protein.
Low-Dose Inhibitor Experiments
In an effort to test the ability of the respiratory conductance assay workflow to localize the source of respiratory resistance to each of
the 3 control nodes listed previously, experiments were conducted using sub-maximal concentrations of the respiratory inhibitors
rotenone (9nM), oligomycin (15nM) and UK5099 (100nM). These inhibitors impact Complex I, Complex V and the pyruvate carrier
specifically and thus should localize resistance to the following control nodes: 1) Substrate delivery and dehydrogenase activity
(UK5099), 2) Electron transport (Rotenone) and 3) ATP synthesis (Oligomycin). Concentrations of each drug were selected following
pilot experiments designed to identify the concentrations required to induce a submaximal drop in respiratory conductance. Slight
modifications to the protocol detailed above were required in order to account for the fact that the impact of each drug on respiratory
conductance was found to be highly dependent on the mitochondrial concentration.e6 Cell Reports 24, 3593–3606.e1–e10, September 25, 2018
UK5099
Reaction master mixes of 2.5ml of Buffer D, supplemented with 5mM creatine, 5mM ATP, 6mM PCr and 20U/ml CK were prepared.
TMRM (0.2 mM), mitochondria (0.1mg/ml) and UK5099 or DMSOwere then added to these master mixes and subsequently added to
respective chambers of theO2K. After an initial5minute temperature equilibration period, 200 mLwas removed from each chamber
and placed in 0.5ml cuvette. Chamber stoppers were then added to the O2K and respiration was assessed as described above.
Cuvettes were placed inside the QuantaMaster Spectrofluorometer (Horiba Scientific) and DJ and NAD(P)H/NAD(P)+ redox assess-
ments were carried out as detailed above. Additions during the assay were Pyr/Mal (1mM/2.5mM), 3mMPCR (total = 9mM) and 6mM
PCR (total = 15mM), followed by CN (4mM). UK5099 was made up in DMSO as a 160mM stock.
Rotenone/Oligomycin
Reaction master mixes of 2.5ml of Buffer D, supplemented with 5mM creatine, 5mM ATP, 6mM PCr and 20U/ml CK were prepared.
TMRM (0.2uM), mitochondria (0.1mg/ml) and Rotenone (9nM), Oligomycin (15nM) or DMSO were then added to these master mixes
and subsequently added to respective chambers of the O2K. After an initial 5 minute temperature equilibration period, 200uL was
removed from each chamber and placed in a cuvette. Chamber stoppers were then added to the O2K and respiration was assessed
as described above. Cuvettes were placed inside the QuantaMaster Spectrofluorometer (Horiba Scientific) and DJ and NAD(P)H/
NAD(P)+ redox assessments were carried out as detailed above. Additions during the assay were Oct/M (0.2mM/2.5mM), 3mM
PCR (total = 9mM) and 6mM PCR (total = 15mM), followed by CN (4mM). Rotenone and oligomycin were prepared in DMSO as
30mM stocks.
Mitochondrial JH2O2 Emission
Mitochondrial H2O2 emissionwasmeasured fluorometrically via the Amplex Ultra Red (AUR)/horseradish peroxidase (HRP) detection
system (Ex:Em 565:600) as described previously (Fisher-Wellman et al., 2013a), with slight modifications. Fluorescence was moni-
tored via a QuantaMaster Spectrofluorometer (Horiba Scientific). For each experiment, resorufin fluorescence was converted to
pmoles H2O2 via an H2O2 standard curve generated under identical substrate conditions as employed for each protocol. All exper-
iments were carried out at 37C in a 0.2ml reaction volume. Buffer for all assays was Buffer D, supplemented with creatine (Cr; 5mM),
phosphocreatine (PCr; 1mM), creatine kinase (CK; 20U/ml), AUR (10 mM), HRP (1U/ml) and superoxide dismutase (20U/ml). To begin,
isolatedmitochondria (0.1mg/ml) were added to assay buffer, followed by the addition of respiratory substrates (Oct/M, G/M, Pyr/M),
auranofin (0.1 mM), ATP (5mM), and then sequential PCr additions to a final of 6, and 15mM. The percentage of electron leak is
calculated by dividing the rate of H2O2 production by the corresponding O2 consumption rate measured under identical conditions
and expressed as a percentage (% Leak = JH2O2/JO2*100). Of note, the JH2O2 rates used in the calculation were generated in the
presence of auranofin; however, the corresponding JO2 assays did not contain auranofin, as the inhibitor was found to not impact
respiratory conductance.
Assay Rationale
During the process of OXPHOS, a small percentage of electrons are prematurely leaked to O2, thus yielding the superoxide radical
(O2-,). The majority of superoxide produced is rapidly converted to H2O2 via superoxide dismutase (SOD) located in the matrix
(mg-SOD) or inner-mitochondrial membrane (Cu/Zn-SOD). This assay measures the rate of H2O2 appearance in the buffer as it
diffuses from the point of origin within the electron transport system and/or matrix across the mitochondrial membranes. Amplex
Ultra Red reacts with the H2O2 in the presence of horse radish peroxidase to generate the fluorescence compound resorufin. Excess
SOD is included in the assay buffer to ensure that any superoxide diffusing from the mitochondria is rapidly converted to H2O2.
A portion of the H2O2 generated within the matrix is buffered by the endogenous antioxidant buffering networks (e.g., thioredoxin
reductase system, glutathione reductase system), thus in the absence of any inhibitors of these buffering systems, the measured
rate of H2O2 emission represents the net H2O2 (H2O2 produced – H2O2 buffered = H2O2 emitted). The principle buffering system
in skeletal muscle and heart mitochondria is the thioredoxin system (Fisher-Wellman et al., 2015), thus inclusion of the thioredoxin
reductase inhibitor auranofin in the assay provides a more accurate approximation of the total H2O2 produced under any respiratory
substrate condition. A variety of chemicals can interfere with resorufin fluorescence and thus H2O2 standard curves must be run
under all specified substrate/inhibitor conditions in order to achieve accurate quantitation of H2O2.
JATP Synthesis
Rates of ATP synthesis were determined as described previously (Lark et al., 2016) with slight modifications. Buffer for the assay was
Buffer D, supplemented with glucose (5mM), hexokinase (1U/ml), glucose-6-phosphate dehydrogenase (G6PDH; 2U/ml), NADP+
(2mM) and ADP (0.2mM). Assay buffer (200 mL) was loaded into individual wells of a 96-well plate, followed by isolated mitochondria
(2 mg/well). The assay was initiated with the addition of respiratory substrates following a 5 minute pre-incubation at 37C in the
absence of substrates to deplete endogenous metabolites. In the assay, NADPH and ATP are produced in a 1:1 stoichiometry
and thus JATPwas determined viamonitoring the NADPH auto-fluorescence (Ex:Em 340/450) signal. Fluorescence values were con-
verted to pmoles of ATP via an ATP standard curve. The following substrate conditions were tested in parallel for each assay [Oct/M;
0.2/2.5mM, G/M; 10/2.5mM, Pyr/M; 5/2.5mM, Succ/R; 10/0.005mM]. Pilot experiments were performed to assess ATP production
from the other known mitochondrial ATP generating enzyme adenylate kinase (mAK). These assays were performed in the presence
and absence of themAK inhibitor P1,P5-Di(adenosine-50)pentaphosphate (AP5A; 0.2mM) (Kurebayashi et al., 1980). Under the assay
conditions utilized herein, AP5A was found to exert no impact on mitochondrial JATP and thus was excluded (Figures S5B and S5C).Cell Reports 24, 3593–3606.e1–e10, September 25, 2018 e7
Assay Rationale
In this assay, the rate of mitochondrial ATP synthesis (JATP) is assessed via tracking the fluorescence signal generated by NADPH as
it is produced via G6PDH. In short, upon addition of ADP to energized mitochondria (i.e., mitochondria with saturating carbon
substrates), this ADP is converted to ATP via ATP synthase and then exported back into the buffer via the adenine nucleotide trans-
locase (ANT). Once in the buffer, the newly synthesized ATP is converted back to ADP via hexokinase (glucose + ATP > glucose-6-
phosphate + ADP). Through an enzyme-coupled mechanism, the G6P along with NADP+ (present in the buffer) is then converted to
6-phospho-D-glucono-1,5-lactone and NADPH via G6PDH. In this assay system, ATP and NAPDH are produced at 1:1 stoichiom-
etry, thus the rate of NADPH generation serves as a measure of mitochondrial ATP synthesis.
JNADH and JNADPH Production
Rates of NADH and NADPH production were determined as described previously (Fisher-Wellman et al., 2013a) with slight modifi-
cations. Buffer for the assays was Buffer D, supplemented with alamethicin (0.03mg/ml), rotenone (0.005mM) and NAD+ (2mM) or
NADP+ (2mM). For experiments designed to assess JNADH from the pyruvate dehydrogenase complex (PDH), the alpha-ketogluta-
rate dehydrogenase complex (AKGDH) and the branched-chain keto-acid dehydrogenase complex (BCKDH) the followed cofactors
were included in the assay: coenzyme A (0.1mM) and thiamine pyrophosphate (0.3mM). Rates of NADPH production from glutamate
dehydrogenase (GDH) were determined in the absence and presence of ADP (5mM). Assay buffer (200 mL) was loaded into individual
wells of a 96-well plate, followed by isolated mitochondria (2-60 mg/well). The assay was initiated with the addition of enzymatic
substrates. In the assay, NADH and NADPH were determined via auto-fluorescence (Ex:Em 340/450). Fluorescence values were
converted to pmoles of NADH or NADPH via an NADH/NADPH standard curve. The following substrates were tested in parallel
for each assay [pyruvate (5mM), alpha ketoglutarate (10mM), a-keto-b-methylvalerate (5mM), glutamate (10mM), malate (5mM),
isocitrate (5mM)].
Assay Rationale
In this assay, the activity of soluble matrix dehydrogenase enzymes are assessed in isolated mitochondria following chemical per-
meabilization of the inner mitochondrial membrane with the pore-forming peptide alamethicin. Permeabilization with alamethicin is
required to allow for specific enzyme cofactors (e.g., CoA, thiamine pyrophosphate, NAD+, NADP+) to traverse the mitochondrial in-
ner-membrane and activate matrix dehydrogenases. Once inside the matrix, NAD+ and NADP+ are converted to NADH and NADPH,
which then diffuse back out into the buffer and are measured via fluorescence. The rate of NADH/NADPH appearance in the buffer
indicates dehydrogenase activity. Specific dehydrogenases are targeted via the addition of specific carbon substrates and cofactors
(e.g., pyruvate along with CoA, thiamine pyrophosphate and NAD+ activates the pyruvate dehydrogenase complex while malate
along with NADP+ activates malic enzyme).
CV Activity Assay
CV activity was assessed as described previously (Barrientos et al., 2009) with slight modifications. Mitochondrial lysates for the
assay were prepared via dilution of the final isolated mitochondrial suspensions in CelLytic M (Sigma-Aldrich; C2978) at a protein
concentration of 2mg/ml. Buffer for the assay was Buffer E, supplemented with lactate dehydrogenase/pyruvate kinase (10U/ml),
phosphoenoyl-pyruvate (5mM), rotenone (0.005mM) and NADH (0.2mM). Assay buffer (200 mL) was loaded into individual wells of
a 96-well plate, followed by mitochondrial lysate (2 mg/well). Assays were done in the absence and presence of oligomycin
(0.005mM) in order to calculate the oligomycin-sensitive rates of ATP hydrolysis. The assay was initiated with the addition of ATP
(5mM). In the assay, NADH oxidation and ATP hydrolysis occur at a 1:1 stoichiometry and thus CV activity (pmoles of ATP/sec/mg)
was determined via tracking the degradation in the NADH auto-fluorescence (Ex:Em 376/450) signal upon ATP addition. Fluores-
cence values were converted to pmoles of NADH via an NADH standard curve.
Assay Rationale
In this assay, the activity of mitochondrial ATP synthase is assessed in the forward direction (i.e., ATP hydrolysis) via an enzyme-
coupled mechanism. To begin, isolated mitochondria are first solubilized in a non-denaturing, low-percentage detergent buffer
(CelLytic M), which serves to liberate intact ATP synthase from the inner mitochondrial membrane. Alamethicin-permeabilized mito-
chondria can also be used for this assay, but in our hands the dynamic range of the assay is improved upon the use of CelLyticM. This
likely stems from the greater stability of NADH at alkaline pH (e.g., pH = 8.0), compared to the pH of the alamethicin-permeabilization
buffer (pH = 7.1). Upon addition of ATP, ATP synthase hydrolyzes the ATP to ADP, which is then converted back to ATP via pyruvate
kinase (ADP + phosphoenoyl-pyruvate > ATP + pyruvate). The pyruvate is then converted to lactate in the presence of NADH (present
in the buffer at 0.2mM), thus generating NAD+. ATP hydrolysis and NADH oxidation occur at 1:1 stoichiometry, thus the rate of disap-
pearance of NADH (assessed via fluorescence) serves as an indicator of ATP synthase activity. To control for ATP hydrolysis by
enzyme systems other than ATP synthase, the assay is performed in the absence and presence of ATP synthase inhibitor oligomycin.
The rate of NADH disappearance measured in the presence of oligomycin is subtracted from the rate of NADH disappearance
measured in the absence of the inhibitor and thus the final rate represents ATP synthase-dependent activity only.
Hydroxyacyl-CoA Dehydrogenase Activity
Mitochondrial lysates for the assaywere prepared via dilution of the final isolatedmitochondrial suspensions in CelLyticM at a protein
concentration of 2mg/ml. Buffer for the assaywas Buffer E, supplementedwith rotenone (0.005mM) andNADH (0.2mM). Assay buffere8 Cell Reports 24, 3593–3606.e1–e10, September 25, 2018
(200 mL) was loaded into individual wells of a 96-well plate, followed by mitochondrial lysate (5 mg/well). The assay was initiated with
the addition of acetoacetyl-CoA (0.2mM). The activity of hydroxyacyl-CoA dehydrogenase was determined via tracking the degra-
dation in the NADH auto-fluorescence (Ex:Em 340/450) signal upon acetoacetyl-CoA addition. Fluorescence values were converted
to pmoles of NADH via an NADH standard curve.
Assay Rationale
Hydroxyacyl-CoA dehydrogenase (Hadha) is the primary NAD+-linked dehydrogenase within the beta-oxidation pathway. In this
assay, the activity of Hadha is assessed in the reverse direction by tracking the rate of NADH disappearance upon oxidation of ace-
toacetyl-CoA. To begin, isolated mitochondria are first solubilized in a non-denaturing, low-percentage detergent buffer (CelLytic M),
which serves to solubilize the mitochondria outer and inner membrane and allow access to Hadha. Alamethicin-permeabilized mito-
chondria can also be used for this assay, but in our hands the dynamic range of the assay is improved upon the use of CelLytic M.
GOT2 Activity
Mitochondrial lysates for the assaywere prepared via dilution of the final isolatedmitochondrial suspensions in CelLyticM at a protein
concentration of 2mg/ml. Buffer for the assay was Buffer E, supplemented with aspartate (200mM), pyridoxal 50-phosphate (0.1mM),
malate dehydrogenase (2U/ml), rotenone (0.005mM) and NADH (0.2mM). Assay buffer (200 mL) was loaded into individual wells of a
96-well plate, followed by mitochondrial lysate (10 mg/well). The assay was initiated with the addition of AKG (12mM). The activity of
GOT2 was determined via tracking the degradation in the NADH auto-fluorescence (Ex:Em 340/450) signal upon AKG addition (Siest
et al., 1975). Fluorescence values were converted to pmoles of NADH via an NADH standard curve.
Assay Rationale
GOT2 catalyzes a transamination reaction whereby aspartate and AKG are converted to glutamate and oxaloacetate. In this assay,
GOT2 present in the mitochondrial lysate generates glutamate and oxaloacetate from aspartate and AKG present in the buffer.
Excess malate dehydrogenase also present in the assay buffer converts the oxaloacetate into malate at the expense of NADH
oxidation.
Proton Leak Kinetics
Mitochondrial proton leak was assessed in Buffer D, supplemented with oligomycin (0.005mM) and TMRM (0.2 mM). Reactionmaster
mixes of 2.5ml of the experimental buffer were prepared which contained mitochondria (0.1mg/ml) and added to respective cham-
bers of the O2K. After an initial 5 minute temperature equilibration period, 200 mL was removed from each chamber and placed in
0.5ml cuvette. Chamber stoppers were then added to the O2K and respiration was assessed. Cuvettes were placed inside the
QuantaMaster Spectrofluorometer (Horiba Scientific) and DJ assessments were carried out as detailed above. Additions during
the assay were Pyr/M (1mM/2.5mM) and sequential additions of UK5099 (2, 4, 6, 8 mM).
Assay Rationale
The assay allows for proton leak (i.e., respiration in the presence of the ATP synthase inhibitor oligomycin) and DJ to be assessed
over time as leak rates are sequentially adjusted by the pyruvate carrier inhibitor, similar to that described previously for Succ/R sub-
strate conditions (Affourtit et al., 2012). Plotting JO2 against DJ during the assay allows for the determination of maximal proton leak
(i.e., JO2 in the absence of UK5099), as well as the leak rates at the highest common membrane potential. Because proton leak is
determined primarily by DJ, the latter measurement normalizes proton leak to DJ and as such allows for a direct comparison of
proton leak potential (Divakaruni and Brand, 2011).
Free Magnesium Quantification
Fluorescent determination of free magnesium concentration was performed in a QuantaMaster Spectrofluorometer (Horiba
Scientific). The assay buffer was Buffer D, supplemented with creatine (Cr; 5mM), phosphocreatine (PCr; 1mM), creatine kinase
(CK; 20U/ml), and 1mM Magnesium Green (ThermoFisher Scientific M3733). The fluorescent signal (Ex:Em 475:530 nm) was






Fmax  F  0:055mM
where Fmin and Fmax represent the signal with saturating concentrations of EDTA or MgCl2, respectively. The dissociation constant,
Kd, is 1mM (Chinopoulos et al., 2009). This measurement was performed following the addition of ATP (5 mM) and sequential PCr
additions to a final concentration of 3, 6, 9,12, 15, 18, 21, 24, 30mM. The concentrations of free magnesium were used in calculating
the DG’ATP over the CK clamp.
Experimental Logistics and Practical Considerations
Although the current data were generated using mitochondria derived from mouse muscle and cardiac tissues, the entire suite of
assays should be easily adaptable for studies using other tissues that are enriched in mitochondria, such as brain, liver and brown
adipose tissue. For tissues with lower mitochondrial content (e.g., white adipose tissue, smooth muscle, pancreas, ext.), pooling of
several rodents might be necessary in order to acquire sufficient material for the entire collection of assays. Assuming the incorpo-
ration of 4 unique substrate combinations, the minimum mitochondrial requirements to perform the entire battery of assays in theCell Reports 24, 3593–3606.e1–e10, September 25, 2018 e9
screening platform is 0.44mgs (O2K experiments 0.05mg/substrate condition; DJ/NAD(P)H/NAD(P)+ experiments 0.02mg/sub-
strate condition; Electron Leak experiments0.02mg/substrate condition; JATP synthesis0.005mg/substrate conditions; Enzyme
activity assays 0.005mg/assay).
Moreover, we believe the platform can also be adapted for application to permeabilized cell systems. Efforts to optimize the
platform for new applications must consider several critical factors, including: a) tissue and cell type-specific differences in matrix
dehydrogenase profiles, b) prioritization of substrate conditions when mitochondrial yield is limiting, and c) purity of tissue-specific
mitochondrial isolations and potential need for sucrose- or Percoll-based purification protocols (Glancy and Balaban, 2011; Graham,
2001). To this point, it is noteworthy that the simple isolation protocol (without a sucrose-based buffer) used in the current work was
sufficient to produce fractions with similar amounts of mitochondrial protein between tissues (Figures S4A and S4B). However,
additional mitochondrial purification may be required for tissue types in which cytosolic, ER and/or lipid contamination within the
mitochondrial fraction is more problematic. These considerations could become more important in studies where proteomics
analyses are desired (Glancy and Balaban, 2011). Finally, the substrate conditions employed herein were selected to cover the
primary metabolic pathways operating in muscle mitochondria, as evidenced by the dehydrogenase profiles of the tissues. That
said, mitochondria from different tissues possess distinct dehydrogenase profiles, thus initial pilot studies may be required in order
to determine the most relevant substrate combinations for assessing any specific mitochondrial population.
QUANTIFICATION AND STATISTICAL ANALYSIS
Data are presented asmean ± SEM. Differences between groups were analyzed by Student’s t tests or among groups using one-way
ANOVAwith Tukey’smultiple comparison tests. The level of significancewas set at p < 0.05. Figures were generated usingGraphPad
Prism (Version 7.0). Statistical details of each experiment are located in the figure legends. Unless otherwise stated, the number of
mice per experiment is represented by ‘‘N.’’
ADDITIONAL RESOURCES
Ionic strength, pH, free magnesium, temperature, and pressure affect the apparent equilibrium constants of biochemical reactions.
At each step of theCK clamp, ionic strength and freemagnesium are altered. Therefore, accurate bioenergetic quantification requires
the creatine kinase and ATP hydrolysis equilibrium constants be adjusted (Golding et al., 1995; Teague et al., 1996). Implementing
this calculation proved tedious and prompted the development of a simplified web resource. First, a Jupyter notebook containing the
adjustment calculations interspersed with procedural descriptions is provided. The calculations are rendered in the Python program-
ming language and intended to serve as an instructional overview. The second component is a web-based calculator that performs
the bioenergetic adjustments for user-specified conditions. The source code for this calculator is publicly available from the resource
link.
Supplemental Resource #1 – https://github.com/dmpio/bioenergetic-calculators/blob/master/jupyter_notebook/creatine-
kinase-clamp.ipynb
Supplemental Resource #2 - https://dmpio.github.io/bioenergetic-calculators/ck_clamp/e10 Cell Reports 24, 3593–3606.e1–e10, September 25, 2018
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Figure S1. The presence of Na+ impairs respiratory conductance. Related to Figure 1 and Star Methods – “Mitochondrial 
Respiratory Control”. 
(A) Representative trace displaying oxygen consumption in skeletal muscle mitochondria pre-incubated with NaCl (10 mM) or vehicle and
energized with G/M (10/2.5 mM), followed by the addition of ADP (1 mM). (B) ADP-dependent JO2 in skeletal muscle mitochondria
respiring on G/M and pre-incubated with NaCl or vehicle. (C) JATP synthesis in skeletal muscle mitochondria energized with G/M in the
absence or presence of NaCl (10 mM). (D-E) Phosphocreatine titration experiments performed in skeletal muscle mitochondria energized
with G/M (D) and heart mitochondria energized with Oct/M (E) in which the PCr was supplied as either di-sodium phosphocreatine (Na+) or
di-tris phosphocreatine (Tris+). ATP in each experiment was added as either a sodium or tris salt for consistency. (F) Calculated linear slopes
(i.e., respiratory conductance) from the experiments in panels F-G. (G-H) Phosphocreatine titration experiments performed in heart
mitochondria prepared without trypsin or EDTA and energized with Oct/M in which the PCr was supplied as either di-sodium
phosphocreatine (Na+) or di-tris phosphocreatine (Tris+). ATP in each experiment was added as either a sodium or tris salt for consistency. (H)
Calculated linear slopes (i.e., respiratory conductance) from the experiments in panels G. Data are mean ± SEM. Differences between groups
were analyzed by unpaired 2-tailed t-tests. *P<0.05. N=3-5/group, where “N” represents 3-4 biological replicates (i.e., mitochondrial
preparations).
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Figure S2. Approximation of mitochondrial  via TMRM and measurement of NAD(P)H/NAD(P)+ redox state under varying ATP 
free energies. Related to Star Methods – “Mitochondrial membrane potential (ΔΨ) and NAD(P)H/NAD(P)+ Redox” and 
“Mitochondrial membrane potential (ΔΨ) using a TPP+ selective electrode”. 
(A) Relationship between JO2 and ∆GATP in isolated skeletal muscle mitochondria in the presence of TMRM (0.2 M) or DMSO.
Experiments were carried out in Buffer D, supplemented with ATP (5 mM), Cr (5 mM), PCr (3 mM) and 20U/ml CK. Assay additions were
mitochondria (0.025 mg/ml), G/M and PCr x 4 (3 mM additions each). (B) Excitation and emission scans carried out in Buffer D,
supplemented with TMRM (0.2 M) and FCCP (5 M) or ethanol. Mitochondria from skeletal muscle (0.1 mg/ml) were present for all
experiments. (C) Excitation spectra calculated from the difference in fluorescence intensity between scans performed in the absence and
presence of FCCP displayed in panel B (e.g., (EX Scan – EX Scan (+FCCP)) = Ex Diff). The peaks of each spectra are indicated by black
arrows and the difference between them (572-551 = 21) is the quantified spectral shift experienced by TMRM as it accumulates in energized
mitochondria. (D) Representative trace showing TMRM fluorescence at Ex/Em: 551:590 and Ex/Em: 572/590 during a CK clamp
experiment in isolated heart mitochondria. (E) The ratio of emission intensities calculated from the experiment depicted in panel D recorded
at excitation wavelengths of 572 and 551. (F) Representative trace displaying a  standard curve whereby the TMRM fluorescence ratio
(572/551) was plotted against time. Protocol additions were heart mitochondria (Mito, 0.1 mg/ml), valinomycin (Valino, 40 ng/ml), and KCl
(indicated by numbered black arrows). The table below indicates the extra-mitochondrial [KCl] at each titration step, as well as the calculated
 according to the Nernst equation. (G) TMRM fluorescence ratio (572/551) plotted against the calculated  (-mV). (H) Representative
trace showing  assessment using a TPP+ selective electrode during a phosphocreatine titration experiment. (I) Relationship between 
and ∆GATP in isolated skeletal muscle mitochondria energized with Pyr/M. Membrane potential was assessed using either TMRM or a TPP+
selective electrode. (J) Change in , expressed in mVs, during the phosphocreatine titration experiments depicted in panel I using both
experimental methodologies. (K) Representative trace showing NAD(P)H auto-fluorescence (Ex/Em: 340/450) during a CK clamp
experiment in isolated heart mitochondria. The annotated sections of the trace utilized to calculate % Reduction correspond to isolated
mitochondria devoid of substrates (0% Reduced) and the addition of cyanide (100% Reduced). (L) The % Reduction in the
NAD(P)H/NAD(P)+ redox state calculated from the experiment depicted in panel K. (A, G-J) Data are mean ± SEM. Differences between
groups were analyzed by 2-tailed unpaired t-tests. N=3-4/group, where “N” represents 3-4 biological replicates (i.e., mitochondrial
preparations).













































Figure S3. Related to Star Methods – “Mitochondrial JH2O2 Emission”. 
(A) Resorufin fluorescence plotted against H2O2 in pmoles during H2O2 standard curve experiments performed in the presence of vehicle
alone (Control), AF (0.1 M), AF plus ATP (AF/ATP; 0.1 M/5mM) and AF plus ATP and PCr (AF/ATP/PCR; 0.1 M/5mM/9mM). (B)
Calculated slopes from the experiments depicted in panel A. Data are mean ± SEM. Differences between groups were analyzed by 2-tailed
unpaired t-tests comparing each group to the control (Ctr). *P<0.05. N=3/group, where “N” represents 3 biological replicates (i.e.,
mitochondrial preparations).




Figure S4. Related to Figures 4 and 6. 
(A) Immunoblot analysis of CIII, CIV and CV in skeletal muscle and heart isolated mitochondria lysates. (B) Quantification of the
blots depicted in panel A. (C) Relationship between mitochondrial JO2 versus ATP free energy (∆GATP) in mitochondria energized with
AKG (10 mM). (D) Calculated slopes from the linear portions of the data depicted in panel A. (E) Relationship between mitochondrial
NAD(P)H/NAD(P)+ redox versus ATP free energy (∆GATP) in mitochondria energized with G/M in the presence of 0.6 mM CaCl2 (free Ca+ ~
500nM). (F-G) Mitochondria JO2 plotted against  in the presence of Pyr/M (F) and Succ/Rot (G) in percoll purified mitochondria. Data
are mean ± SEM. Differences between groups were analyzed by 2-tailed unpaired t-tests. (A-F) N=4-6 individual mice/group, (G) N=2
individual mice/group.


































































































Figure S5. Related to Figure 6 and Star Methods – “JATP Synthesis”. 
(A) Representative trace from a CV activity assay performed in isolated mitochondria from skeletal muscle in the absence (- Oligo) and
presence (+ Oligo) of oligomycin (5 M). (B) Representative trace from a JATP synthesis assay performed in the presence and absence of
AP5A. (C) Effect of AP5A on JATP in skeletal muscle and heart mitochondria, expressed as fold change (FC). (D) Oxygen consumption in
mitochondria energized with Pyr/M in the presence of oligomycin following sequential additions of the pyruvate carrier inhibitor UK5099 to
titrate redox state and . (E) Relationship between proton leak and  assessed in the presence of oligomycin and Pyr/M suggests similar
proton leak rates between the two groups. Black arrow indicates leak rates at the highest common . Data are mean ± SEM. Differences
between groups were analyzed by 2-tailed unpaired t-tests. N=4-6 individual mice/group.
